CN117956820A - Organic electroluminescent material and device - Google Patents
Organic electroluminescent material and device Download PDFInfo
- Publication number
- CN117956820A CN117956820A CN202311406125.XA CN202311406125A CN117956820A CN 117956820 A CN117956820 A CN 117956820A CN 202311406125 A CN202311406125 A CN 202311406125A CN 117956820 A CN117956820 A CN 117956820A
- Authority
- CN
- China
- Prior art keywords
- compound
- oled
- group
- compounds
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title abstract description 177
- 150000001875 compounds Chemical class 0.000 claims abstract description 746
- SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 claims abstract description 140
- 238000012546 transfer Methods 0.000 claims abstract description 50
- 125000001424 substituent group Chemical group 0.000 claims description 66
- 125000003118 aryl group Chemical group 0.000 claims description 59
- -1 amino, silyl Chemical group 0.000 claims description 52
- 238000004770 highest occupied molecular orbital Methods 0.000 claims description 50
- 125000000217 alkyl group Chemical group 0.000 claims description 41
- 229910052760 oxygen Inorganic materials 0.000 claims description 41
- 229910052717 sulfur Inorganic materials 0.000 claims description 40
- 238000006467 substitution reaction Methods 0.000 claims description 36
- 229910052757 nitrogen Inorganic materials 0.000 claims description 35
- 229910052799 carbon Inorganic materials 0.000 claims description 34
- 125000001072 heteroaryl group Chemical group 0.000 claims description 33
- 239000003446 ligand Substances 0.000 claims description 33
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 229910052751 metal Inorganic materials 0.000 claims description 28
- 239000002184 metal Substances 0.000 claims description 28
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims description 27
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 27
- 239000001257 hydrogen Substances 0.000 claims description 27
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 claims description 26
- 230000005855 radiation Effects 0.000 claims description 26
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 claims description 24
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 22
- 229910052805 deuterium Inorganic materials 0.000 claims description 22
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 claims description 21
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- 125000003342 alkenyl group Chemical group 0.000 claims description 17
- 229960005544 indolocarbazole Drugs 0.000 claims description 16
- 150000002825 nitriles Chemical class 0.000 claims description 16
- 101100083446 Danio rerio plekhh1 gene Proteins 0.000 claims description 15
- 125000000304 alkynyl group Chemical group 0.000 claims description 15
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 14
- 229910000085 borane Inorganic materials 0.000 claims description 14
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 14
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 14
- 229910052796 boron Inorganic materials 0.000 claims description 13
- VVVPGLRKXQSQSZ-UHFFFAOYSA-N indolo[3,2-c]carbazole Chemical compound C1=CC=CC2=NC3=C4C5=CC=CC=C5N=C4C=CC3=C21 VVVPGLRKXQSQSZ-UHFFFAOYSA-N 0.000 claims description 13
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 12
- SQXZDPPQQUQRSW-UHFFFAOYSA-N 1h-imidazo[1,2-a]benzimidazole Chemical compound C1=CC=C2N3CC=NC3=NC2=C1 SQXZDPPQQUQRSW-UHFFFAOYSA-N 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000004104 aryloxy group Chemical group 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 12
- 150000002527 isonitriles Chemical class 0.000 claims description 12
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 12
- 101100129500 Caenorhabditis elegans max-2 gene Proteins 0.000 claims description 11
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 claims description 11
- 150000002148 esters Chemical class 0.000 claims description 11
- 229910052711 selenium Inorganic materials 0.000 claims description 11
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 11
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 11
- 125000005580 triphenylene group Chemical group 0.000 claims description 11
- OBZNQOXNXVLYRM-UHFFFAOYSA-N 8,14-dioxa-1-borapentacyclo[11.7.1.02,7.09,21.015,20]henicosa-2,4,6,9(21),10,12,15,17,19-nonaene Chemical compound C1=CC=CC=2OC=3C=CC=C4OC=5C=CC=CC5B(C34)C12 OBZNQOXNXVLYRM-UHFFFAOYSA-N 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- WIUZHVZUGQDRHZ-UHFFFAOYSA-N [1]benzothiolo[3,2-b]pyridine Chemical compound C1=CN=C2C3=CC=CC=C3SC2=C1 WIUZHVZUGQDRHZ-UHFFFAOYSA-N 0.000 claims description 10
- 125000002252 acyl group Chemical group 0.000 claims description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 10
- DHFABSXGNHDNCO-UHFFFAOYSA-N dibenzoselenophene Chemical compound C1=CC=C2C3=CC=CC=C3[se]C2=C1 DHFABSXGNHDNCO-UHFFFAOYSA-N 0.000 claims description 10
- 125000003636 chemical group Chemical group 0.000 claims description 8
- BPMFPOGUJAAYHL-UHFFFAOYSA-N 9H-Pyrido[2,3-b]indole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=N1 BPMFPOGUJAAYHL-UHFFFAOYSA-N 0.000 claims description 7
- 125000005647 linker group Chemical group 0.000 claims description 7
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 claims description 7
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 6
- 125000003800 germyl group Chemical group [H][Ge]([H])([H])[*] 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- TWPXHCXUAJNQEB-UHFFFAOYSA-N boranylphosphane Chemical compound PB TWPXHCXUAJNQEB-UHFFFAOYSA-N 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 229910052738 indium Inorganic materials 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 67
- 238000000034 method Methods 0.000 abstract description 33
- 238000010549 co-Evaporation Methods 0.000 abstract description 11
- 238000009472 formulation Methods 0.000 abstract description 10
- 239000010410 layer Substances 0.000 description 279
- 239000000370 acceptor Substances 0.000 description 124
- 230000003111 delayed effect Effects 0.000 description 41
- 230000005281 excited state Effects 0.000 description 36
- 102000005962 receptors Human genes 0.000 description 36
- 108020003175 receptors Proteins 0.000 description 36
- 239000010409 thin film Substances 0.000 description 25
- 230000004888 barrier function Effects 0.000 description 24
- 239000012044 organic layer Substances 0.000 description 24
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 23
- 239000002019 doping agent Substances 0.000 description 19
- 239000000758 substrate Substances 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 238000000151 deposition Methods 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 17
- 125000004122 cyclic group Chemical group 0.000 description 17
- 238000001704 evaporation Methods 0.000 description 17
- 230000032258 transport Effects 0.000 description 17
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 16
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 125000004432 carbon atom Chemical group C* 0.000 description 14
- 150000004696 coordination complex Chemical class 0.000 description 14
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 12
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 12
- 239000007850 fluorescent dye Substances 0.000 description 12
- 125000005842 heteroatom Chemical group 0.000 description 12
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 11
- 230000008020 evaporation Effects 0.000 description 11
- 229910052698 phosphorus Inorganic materials 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 230000003595 spectral effect Effects 0.000 description 10
- 230000000903 blocking effect Effects 0.000 description 9
- 230000008878 coupling Effects 0.000 description 9
- 230000005284 excitation Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 230000007704 transition Effects 0.000 description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 8
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 8
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 8
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000008021 deposition Effects 0.000 description 8
- 239000010408 film Substances 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- 238000005424 photoluminescence Methods 0.000 description 8
- 229910052710 silicon Inorganic materials 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 238000001771 vacuum deposition Methods 0.000 description 8
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 239000004305 biphenyl Substances 0.000 description 7
- 239000003086 colorant Substances 0.000 description 7
- 230000005525 hole transport Effects 0.000 description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 description 7
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 6
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 6
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 6
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 6
- 235000010290 biphenyl Nutrition 0.000 description 6
- 125000006575 electron-withdrawing group Chemical group 0.000 description 6
- 238000000295 emission spectrum Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 150000002894 organic compounds Chemical class 0.000 description 6
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 6
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 6
- 125000006413 ring segment Chemical group 0.000 description 6
- 238000002207 thermal evaporation Methods 0.000 description 6
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 5
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 5
- 239000002096 quantum dot Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- 102100025022 Mannose-6-phosphate isomerase Human genes 0.000 description 4
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 4
- 230000003190 augmentative effect Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 230000009878 intermolecular interaction Effects 0.000 description 4
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 230000005693 optoelectronics Effects 0.000 description 4
- 239000011368 organic material Substances 0.000 description 4
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000000059 patterning Methods 0.000 description 4
- 230000010287 polarization Effects 0.000 description 4
- 125000003367 polycyclic group Chemical group 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 238000010129 solution processing Methods 0.000 description 4
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 4
- 229930192474 thiophene Natural products 0.000 description 4
- 150000003852 triazoles Chemical class 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 3
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 3
- BNRDGHFESOHOBF-UHFFFAOYSA-N 1-benzoselenophene Chemical compound C1=CC=C2[se]C=CC2=C1 BNRDGHFESOHOBF-UHFFFAOYSA-N 0.000 description 3
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 3
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 3
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 3
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 3
- OLGGLCIDAMICTA-UHFFFAOYSA-N 2-pyridin-2-yl-1h-indole Chemical compound N1C2=CC=CC=C2C=C1C1=CC=CC=N1 OLGGLCIDAMICTA-UHFFFAOYSA-N 0.000 description 3
- QMEQBOSUJUOXMX-UHFFFAOYSA-N 2h-oxadiazine Chemical compound N1OC=CC=N1 QMEQBOSUJUOXMX-UHFFFAOYSA-N 0.000 description 3
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 3
- 101000577063 Arabidopsis thaliana Mannose-6-phosphate isomerase 1 Proteins 0.000 description 3
- 101001094831 Homo sapiens Phosphomannomutase 2 Proteins 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003989 dielectric material Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 3
- AZHVQJLDOFKHPZ-UHFFFAOYSA-N oxathiazine Chemical compound O1SN=CC=C1 AZHVQJLDOFKHPZ-UHFFFAOYSA-N 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 3
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 3
- 229950000688 phenothiazine Drugs 0.000 description 3
- 125000004437 phosphorous atom Chemical group 0.000 description 3
- 239000003504 photosensitizing agent Substances 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 3
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 3
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 230000001235 sensitizing effect Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- YJKJAYFKPIUBAW-UHFFFAOYSA-N 9h-carbazol-1-amine Chemical compound N1C2=CC=CC=C2C2=C1C(N)=CC=C2 YJKJAYFKPIUBAW-UHFFFAOYSA-N 0.000 description 2
- 101000577065 Arabidopsis thaliana Mannose-6-phosphate isomerase 2 Proteins 0.000 description 2
- QLBALZYOTXGTDQ-VFFCLECNSA-N PGI2-EA Chemical compound O1\C(=C/CCCC(=O)NCCO)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 QLBALZYOTXGTDQ-VFFCLECNSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- QZLAKPGRUFFNRD-UHFFFAOYSA-N [1]benzoselenolo[3,2-b]pyridine Chemical compound C1=CN=C2C3=CC=CC=C3[se]C2=C1 QZLAKPGRUFFNRD-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 239000000412 dendrimer Substances 0.000 description 2
- 229920000736 dendritic polymer Polymers 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000001912 gas jet deposition Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005283 ground state Effects 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000002346 layers by function Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 2
- 238000013086 organic photovoltaic Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- XDJOIMJURHQYDW-UHFFFAOYSA-N phenalene Chemical compound C1=CC(CC=C2)=C3C2=CC=CC3=C1 XDJOIMJURHQYDW-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- 150000003918 triazines Chemical class 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- HMLURENDJQQGCM-UHFFFAOYSA-N 1-benzothiophene;pyridine Chemical compound C1=CC=NC=C1.C1=CC=C2SC=CC2=C1 HMLURENDJQQGCM-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 150000005360 2-phenylpyridines Chemical class 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DHDHJYNTEFLIHY-UHFFFAOYSA-N 4,7-diphenyl-1,10-phenanthroline Chemical group C1=CC=CC=C1C1=CC=NC2=C1C=CC1=C(C=3C=CC=CC=3)C=CN=C21 DHDHJYNTEFLIHY-UHFFFAOYSA-N 0.000 description 1
- DIVZFUBWFAOMCW-UHFFFAOYSA-N 4-n-(3-methylphenyl)-1-n,1-n-bis[4-(n-(3-methylphenyl)anilino)phenyl]-4-n-phenylbenzene-1,4-diamine Chemical group CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)N(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 DIVZFUBWFAOMCW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000003775 Density Functional Theory Methods 0.000 description 1
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 1
- 229910006095 SO2F Inorganic materials 0.000 description 1
- 229910018162 SeO2 Inorganic materials 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- KCQLSIKUOYWBAO-UHFFFAOYSA-N azaborinine Chemical compound B1=NC=CC=C1 KCQLSIKUOYWBAO-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000004431 deuterium atom Chemical group 0.000 description 1
- IYYZUPMFVPLQIF-ALWQSETLSA-N dibenzothiophene Chemical group C1=CC=CC=2[34S]C3=C(C=21)C=CC=C3 IYYZUPMFVPLQIF-ALWQSETLSA-N 0.000 description 1
- QPJFIVIVOOQUKD-UHFFFAOYSA-N dipyrazino[2,3-f:2,3-h]quinoxaline Chemical group C1=CN=C2C3=NC=CN=C3C3=NC=CN=C3C2=N1 QPJFIVIVOOQUKD-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229910000078 germane Inorganic materials 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical group [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 125000002524 organometallic group Chemical class 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 229940037201 oris Drugs 0.000 description 1
- 150000002916 oxazoles Chemical class 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- KBBSSGXNXGXONI-UHFFFAOYSA-N phenanthro[9,10-b]pyrazine Chemical compound C1=CN=C2C3=CC=CC=C3C3=CC=CC=C3C2=N1 KBBSSGXNXGXONI-UHFFFAOYSA-N 0.000 description 1
- RIYPENPUNLHEBK-UHFFFAOYSA-N phenanthro[9,10-b]pyridine Chemical compound C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=N1 RIYPENPUNLHEBK-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 150000004033 porphyrin derivatives Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000003227 pyridoxines Chemical class 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000001824 selenocyanato group Chemical group *[Se]C#N 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- KTQYWNARBMKMCX-UHFFFAOYSA-N tetraphenylene Chemical group C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C3=CC=CC=C3C2=C1 KTQYWNARBMKMCX-UHFFFAOYSA-N 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- ATVLVRVBCRICNU-UHFFFAOYSA-N trifluorosilicon Chemical compound F[Si](F)F ATVLVRVBCRICNU-UHFFFAOYSA-N 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
- H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
- H10K50/121—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants for assisting energy transfer, e.g. sensitization
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
- H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
The present application relates to organic electroluminescent materials and devices. Provided is an organic light emitting device OLED including: an anode; a cathode; and an emissive region disposed between the anode and the cathode; wherein the emission area comprises: compound S1; a compound A1; compound S2; and compound A2; wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2; wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter; wherein the compound S1 may be the same as or different from the compound S2; wherein the compound A1 may be the same as or different from the compound A2; and wherein at least one of the following conditions holds: (1) the compound S1 is different from the compound S2; (2) the compound A1 is different from the compound A2. Related formulations, related premix co-evaporation sources, related consumer products, and related methods of making those OLED devices are also provided.
Description
Cross reference to related applications
The present application continues for part of U.S. patent application Ser. No. 18/319,182, filed 5/17/2023, filed herewith. The present application also claims priority from 35 U.S. c. ≡119 (e) to the following U.S. provisional applications: no. 63/419,782 submitted on day 10, month 27 of 2022; no. 63/421,804, submitted on month 2 of 2022, 11; no. 63/387,166 submitted on month 13 of 2022; no. 63/483,647 submitted on month 7 of 2023; no. 63/487,055 submitted on month 27 of 2023; no. 63/459,091 submitted on month 13 of 2023; no. 63/434,161 submitted on month 21 of 2022; no. 63/484,757 submitted on day 14 of 2 of 2023; no. 63/484,786 submitted on day 14 of 2 of 2023; and 63/490,065 filed on day 14, 3, 2023, the entire contents of all applications mentioned above are incorporated herein by reference.
Technical Field
The present disclosure relates generally to novel formulations and novel OLED devices and methods of making and using the OLED devices.
Background
Optoelectronic devices utilizing organic materials are becoming increasingly popular for a variety of reasons. Many of the materials used to fabricate the devices are relatively inexpensive, so organic photovoltaic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials (e.g., their flexibility) may make them more suitable for specific applications, such as fabrication on flexible substrates. Examples of organic optoelectronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, organic scintillators, and organic photodetectors. For OLEDs, organic materials can have performance advantages over conventional materials.
OLEDs utilize organic thin films that emit light when a voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as displays, lighting and backlighting.
One application of emissive molecules is a full color display. Industry standards for such displays require pixels adapted to emit a particular color (referred to as a "saturated" color). In particular, these standards require saturated red, green and blue pixels. Or the OLED may be designed to emit white light. In conventional liquid crystal displays, the emission from a white backlight is filtered using an absorbing filter to produce red, green and blue emissions. The same technique can also be used for OLEDs. The white OLED may be a single emissive layer (EML) device or a stacked structure. The colors may be measured using CIE coordinates well known in the art.
Disclosure of Invention
The present disclosure provides a combination of a phosphorescent emitter or TADF emitter as a sensitizer and more than one acceptor emitter as a TADF emitter, a fluorescent emitter, or a combination of both. Singlet and triplet excitons, which are electrically generated within an OLED device, may be collected by a phosphorescent emitter or a TADF emitter as a sensitizer, and then energy may be transferred to the TADF emitter or a fluorescent emitter serving as an acceptor. This system, which ultimately emits primarily from the acceptor emitter, can have a short transient time similar to a fluorescent emission system, while also effectively collecting all or most of the electrically generated singlet and triplet states.
In one aspect, the present disclosure provides an Organic Light Emitting Device (OLED) comprising: an anode; a cathode; and an emissive region disposed between the anode and the cathode; wherein the emission area comprises: compound S1; a compound A1; compound S2; and compound A2; wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2; wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter; wherein the compound S1 may be the same as or different from the compound S2; wherein the compound A1 may be the same as or different from the compound A2; and wherein at least one of the following conditions holds: (1) the compound S1 is different from the compound S2; (2) the compound A1 is different from the compound A2.
In another aspect, the present disclosure also provides an Organic Light Emitting Device (OLED) comprising: an anode; a first emission region disposed on the anode; a first Charge Generation Layer (CGL) disposed on the first emission region; a second transmission region disposed on the first CGL; and a cathode disposed on the second emission region; wherein the first emission area includes: compound S1; and compound A1; wherein the second emission region includes: compound S2; and compound A2; wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2; wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter; wherein the compound S1 may be the same as or different from the compound S2; and wherein the compound A1 may be the same as or different from the compound A2.
In yet another aspect, the present disclosure further provides a pixel arrangement of a device comprising: a first subpixel comprising a first OLED comprising a first emission region; a second subpixel comprising a second OLED comprising a second emissive region; wherein the first emission area includes: compound S1; and compound A1; wherein the second emission region includes: compound S2; and compound A2; wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2; wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter; wherein the compound S1 may be the same as or different from the compound S2; and wherein the compound A1 may be the same as or different from the compound A2.
In yet another aspect, the present disclosure also provides a formulation comprising different compounds of at least two of the following compounds: compound S1; a compound A1; compound S2; compound A2; a first host compound; wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature; wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature; wherein the compound S1 may be the same as or different from the compound S2; and wherein the compound A1 may be the same as or different from the compound A2; and wherein at least one of the following conditions holds: (1) the compound S1 is different from the compound S2; (2) the compound A1 is different from the compound A2.
In yet another aspect, the present disclosure also provides a premixed co-evaporation source that is a mixture of a first compound and a second compound; wherein the co-evaporation source is a co-evaporation source for a vacuum deposition process or an OVJP process; wherein the first compound and the second compound are selected in different ways from group 1 consisting of: (1) Compound S1; (2) Compound A1; (3) compound S2; (4) Compound A2; (5) a first host compound; and (6) a second host compound; wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature; wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature; wherein the compound S1 may be the same as or different from the compound S2; when the compound S1 is the same as the compound S2, then the mixture is selected from another element in group 1, and wherein the compound A1 may be the same as or different from the compound A2; when the compound A1 is the same as the compound A2, then the mixture is selected from another element in group 1; wherein the first compound has an evaporation temperature T1 of 150 to 350 ℃; wherein the second compound has an evaporation temperature T2 of 150 to 350 ℃; wherein the absolute value of T1-T2 is less than 20 ℃; wherein the first compound has a concentration C1 in the mixture and a concentration C2 in a film formed as follows: placing the mixture in a vacuum deposition tool at a constant pressure between 1X 10 -6 Torr and 1X 10 -9 Torr on a surface positioned at a predefined distance relative to the vaporized mixtureEvaporating at a deposition rate; and wherein the absolute value of (C1-C2)/C1 is less than 5%.
In yet another aspect, the present disclosure further provides a chemical structure/assembly selected from the group consisting of: monomers, polymers, macromolecules and supermolecules, wherein the chemical structure comprises at least two of the following components: compound S1; a compound A1; compound S2; compound A2; and a first host compound; wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature; wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature; wherein the compound S1 may be the same as or different from the compound S2; and wherein the compound A1 may be the same as or different from the compound A2; and wherein at least one of the following conditions holds: (1) the compound S1 is different from the compound S2; (2) the compound A1 is different from the compound A2.
In yet another aspect, the present disclosure further provides a method for manufacturing an organic light emitting device, the method comprising: providing a substrate having a first electrode disposed thereon; depositing a first organic layer over the first electrode by evaporating a premixed co-evaporation source in a high vacuum deposition tool at a chamber base pressure between 1 x 10 -6 torr and 1 x 10 -9 torr, wherein the premixed co-evaporation source is a mixture of a first compound and a second compound; and depositing a second electrode on the first organic layer, wherein the first compound and the second compound are selected from the group 1 consisting of: (1) Compound S1; (2) Compound A1; (3) compound S2; (4) Compound A2; (5) a first host compound; and (6) a second host compound; wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature; wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature; wherein the compound S1 may be the same as or different from the compound S2; wherein when the compound S1 is the same as the compound S2, then the mixture is selected from another element in group 1, and wherein the compound A1 may be the same as or different from the compound A2; wherein when the compound A1 is the same as the compound A2, then the mixture is selected from another element in group 1; wherein the first compound has an evaporation temperature T1 of 150 to 350 ℃; wherein the second compound has an evaporation temperature T2 of 150 to 350 ℃; wherein the absolute value of T1-T2 is less than 20 ℃; wherein the first compound has a concentration C1 in the mixture and a concentration C2 in a film formed as follows: placing the mixture in a vacuum deposition tool at a constant pressure between 1X 10 -6 Torr and 1X 10 -9 Torr on a surface positioned at a predefined distance relative to the vaporized mixtureEvaporating at a deposition rate; and wherein the absolute value of (C1-C2)/C1 is less than 5%.
Drawings
Fig. 1 shows an organic light emitting device.
Fig. 2 shows an inverted organic light emitting device without a separate electron transport layer.
Fig. 3 shows a plot of modeled P-polarized photoluminescence versus angle for emitters with different Vertical Dipole Ratio (VDR) values.
Detailed Description
A. Terminology
Unless otherwise specified, the following terms used herein are defined as follows:
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed" over "a second layer, the first layer is disposed farther from the substrate. Unless a first layer is "in contact with" a second layer, other layers may be present between the first and second layers. For example, a cathode may be described as "disposed over" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
As used herein, and as will be generally understood by those of skill in the art, if the first energy level is closer to the vacuum energy level, then the first "highest occupied molecular orbital" (Highest Occupied Molecular Orbital, HOMO) or "lowest unoccupied molecular orbital" (Lowest Unoccupied Molecular Orbital, LUMO) energy level is "greater than" or "higher than" the second HOMO or LUMO energy level. Since Ionization Potential (IP) is measured as a negative energy relative to the vacuum level, a higher HOMO level corresponds to an IP with a smaller absolute value (a less negative (LESS NEGATIVE) IP). Similarly, a higher LUMO energy level corresponds to an Electron Affinity (EA) with a smaller absolute value (less negative EA). On a conventional energy level diagram with vacuum energy level on top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. The "higher" HOMO or LUMO energy level appears closer to the top of this figure than the "lower" HOMO or LUMO energy level.
As used herein, and as will be generally understood by those of skill in the art, a first work function is "greater than" or "higher than" a second work function if the first work function has a higher absolute value. Since work function is typically measured as a negative number relative to the vacuum level, this means that the "higher" work function is more negative (more negative). On a conventional energy level diagram with the vacuum energy level on top, a "higher" work function is illustrated as being farther from the vacuum energy level in a downward direction. Thus, the definition of HOMO and LUMO energy levels follows a different rule than work function.
The terms "halo", "halogen" and "halo" are used interchangeably and refer to fluoro, chloro, bromo and iodo.
The term "acyl" refers to a substituted carbonyl (-C (O) -R s).
The term "ester" refers to a substituted oxycarbonyl (-O-C (O) -R s or-C (O) -O-R s) group.
The term "ether" refers to the-OR s group.
The term "thio" or "thioether" is used interchangeably and refers to the-SR s group.
The term "selenoalkyl" refers to the-SeR s group.
The term "sulfinyl" refers to the-S (O) -R s group.
The term "sulfonyl" refers to the-SO 2-Rs group.
The term "phosphino" refers to a group containing at least one phosphorus atom for bonding to a related molecule, common examples such as, but not limited to, -P (R s)2 group or-PO (R s)2 group, where each R s may be the same or different).
The term "silane group" refers to a group containing at least one silicon atom for bonding to a related molecule, common examples such as, but not limited to, -Si (R s)3 groups, where each R s may be the same or different).
The term "germyl" refers to a group containing at least one germanium atom for bonding to a related molecule, common examples such as, but not limited to, -Ge (R s)3 groups, where each R s may be the same or different.
The term "borane" refers to a group containing at least one boron atom for bonding to a related molecule, common examples such as, but not limited to, -B (R s)2 group or its lewis adduct-B (R s)3 group, where R s may be the same or different).
In each of the foregoing, R s may be hydrogen or a general substituent as defined in the present application. Preferred R s is selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combinations thereof. More preferably, R s is selected from the group consisting of: alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The term "alkyl" refers to and includes straight and branched chain alkyl groups. Preferred alkyl groups are those containing from one to fifteen carbon atoms, preferably from one to nine carbon atoms, and include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, 2-dimethylpropyl, and the like. In addition, the alkyl group may be further substituted.
The term "cycloalkyl" refers to and includes monocyclic, polycyclic, and spiroalkyl groups. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and include cyclopropyl, cyclopentyl, cyclohexyl, bicyclo [3.1.1] heptyl, spiro [4.5] decyl, spiro [5.5] undecyl, adamantyl, and the like. In addition, cycloalkyl groups may be further substituted.
The term "heteroalkyl" or "heterocycloalkyl" refers to an alkyl or cycloalkyl group, respectively, having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, si and Se, preferably O, S or N. In addition, heteroalkyl or heterocycloalkyl groups may be optionally substituted.
The term "alkenyl" refers to and includes both straight and branched alkenyl groups. Alkenyl is essentially an alkyl group comprising at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl is essentially cycloalkyl including at least one carbon-carbon double bond in the cycloalkyl ring. The term "heteroalkenyl" as used herein refers to an alkenyl group having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, si, ge and Se, preferably O, S or N. Preferred alkenyl, cycloalkenyl or heteroalkenyl groups are those containing from two to fifteen carbon atoms. In addition, alkenyl, cycloalkenyl or heteroalkenyl groups may be further substituted.
The term "alkynyl" refers to and includes both straight and branched chain alkynyl groups. Alkynyl is essentially an alkyl group that includes at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those containing from two to fifteen carbon atoms. In addition, alkynyl groups may be further substituted.
The term "aralkyl" or "arylalkyl" is used interchangeably and refers to an alkyl group substituted with an aryl group. In addition, the aralkyl group may be further substituted.
The term "heterocyclyl" refers to and includes aromatic and non-aromatic cyclic groups containing at least one heteroatom. Optionally, the at least one heteroatom is selected from O, S, se, N, P, B, si, ge and Se, preferably O, S, N or B. Aromatic heterocyclic groups may be used interchangeably with heteroaryl. Preferred non-aromatic heterocyclic groups are heterocyclic groups containing 3 to 10 ring atoms, preferably 3 to 7 ring atoms, which include at least one heteroatom and include cyclic amines such as morpholinyl, piperidinyl, pyrrolidinyl, and the like, and cyclic ethers/sulfides such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene, and the like. In addition, the heterocyclic group may be further substituted.
The term "aryl" refers to and includes monocyclic and polycyclic aromatic hydrocarbon groups. The polycyclic ring may have two or more rings in which two carbons are common to two adjoining rings (the rings being "fused"). Preferred aryl groups are those containing from six to thirty carbon atoms, preferably from six to twenty four carbon atoms, from six to eighteen carbon atoms, and more preferably from six to twelve carbon atoms. Particularly preferred are aryl groups having six carbons, ten carbons, twelve carbons, fourteen carbons or eighteen carbons. Suitable aryl groups include phenyl, biphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, pyrene,Perylene and azulene, preferably phenyl, biphenyl, triphenylene and naphthalene. In addition, aryl groups may be further substituted or fused, such as, but not limited to, fluorene.
The term "heteroaryl" refers to and includes monocyclic aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. Heteroatoms include, but are not limited to O, S, se, N, P, B, si, ge and Se. In many cases O, S, N or B is a preferred heteroatom. The monocyclic heteroaromatic system is preferably a monocyclic ring having 5 or 6 ring atoms, and the ring may have one to six heteroatoms. The heteropolycyclic system may have two or more aromatic rings in which two atoms are common to two adjoining rings (the rings being "fused"), wherein at least one of the rings is heteroaryl. The heteropolycyclic aromatic ring system may have one to six heteroatoms in each ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing from three to thirty carbon atoms, preferably from three to twenty four carbon atoms, from three to eighteen carbon atoms, and more preferably from three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, diazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene (xanthene), acridine, phenazine, phenothiazine, phenoxazine, benzofurandipyridine, benzothiophene pyridine, thienodipyridine, benzoselenophene dipyridine, dibenzofuran, dibenzoselenium, carbazole, indolocarbazole, benzimidazole, triazine, 1, 2-borazine, 1-boron-nitrogen, 1-nitrogen, 4-boron-nitrogen, boron-nitrogen-like compounds, and the like. In addition, heteroaryl groups may be further substituted.
Of the aryl and heteroaryl groups listed above, triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole, and their respective corresponding aza analogues, are of particular interest.
In many cases, the universal substituent is selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, borane, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, selenkyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In some cases, preferred universal substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, borane, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, and combinations thereof.
In some cases, more preferred universal substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, nitrile, thio, and combinations thereof.
In some cases, more preferred universal substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, silyl, aryl, heteroaryl, nitrile, and combinations thereof.
In other cases, the most preferred universal substituents are selected from the group consisting of: deuterium, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The terms "substituted" and "substituted" refer to substituents other than H bonded to the relevant position, such as carbon or nitrogen. For example, when R 1 represents a single substitution, then one R 1 must not be H (i.e., a substitution). Similarly, when R 1 represents a di-substitution, then both R 1 must not be H. Similarly, when R 1 represents zero or no substitution, R 1 may be, for example, hydrogen of available valence of the ring atoms, such as carbon atoms of benzene and nitrogen atoms in pyrrole, or simply no for ring atoms having a fully saturated valence, such as nitrogen atoms in pyridine. The maximum number of substitutions possible in the ring structure will depend on the total number of available valences in the ring atom.
As used herein, "combination thereof" means that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can contemplate from the applicable list. For example, alkyl and deuterium can combine to form a partially or fully deuterated alkyl group; halogen and alkyl may combine to form a haloalkyl substituent; and halogen, alkyl and aryl may combine to form a haloaralkyl. In one example, the term substitution includes a combination of two to four of the listed groups. In another example, the term substitution includes a combination of two to three groups. In yet another example, the term substitution includes a combination of two groups. Preferred combinations of substituents are combinations containing up to fifty atoms other than hydrogen or deuterium, or combinations comprising up to forty atoms other than hydrogen or deuterium, or combinations comprising up to thirty atoms other than hydrogen or deuterium. In many cases, a preferred combination of substituents will include up to twenty atoms that are not hydrogen or deuterium.
The term "aza" in the fragments described herein, i.e., aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more of the C-H groups in the corresponding aromatic ring may be replaced with a nitrogen atom, such as, but not limited to, aza-triphenylene embraces dibenzo [ f, H ] quinoxaline and dibenzo [ f, H ] quinoline. Other nitrogen analogs of the aza-derivatives described above can be readily envisioned by those of ordinary skill in the art, and all such analogs are intended to be encompassed by the terms as set forth herein.
As used herein, "deuterium" refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. patent No. 8,557,400, patent publication No. WO 2006/095951, and U.S. patent application publication No. US2011/0037057 (which are incorporated herein by reference in their entirety) describe the preparation of deuterium-substituted organometallic complexes. Further reference is made to Yan Ming (Ming Yan) et al, tetrahedron (Tetrahedron) 2015,71,1425-30 and Azrote (Atzrodt) et al, german application chemistry (Angew. Chem. Int. Ed.) (review) 2007,46,7744-65, which is incorporated by reference in its entirety, describes the deuteration of methylene hydrogen in benzylamine and the efficient route to replacement of aromatic ring hydrogen with deuterium, respectively.
As used herein, any specifically recited substituents (e.g., without limitation, methyl, phenyl, pyridyl, etc.) include non-deuterated, partially deuterated, and fully deuterated forms thereof. Similarly, substituent classes (e.g., without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc.) also include non-deuterated, partially deuterated, and fully deuterated forms thereof. The chemical structure of H or D is not further indicated to be considered to include its non-deuterated, partially deuterated and fully deuterated forms. Some common minimal partially or fully deuterated groups such as, but not limited to, CD 3、CD2C(CH3)3、C(CD3)3 and C 6D5.
It will be appreciated that when a fragment of a molecule is described as a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or as if it were an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different ways of naming substituents or linking fragments are considered equivalent.
In some cases, a pair of substituents in a molecule may optionally be joined or fused into a ring. Preferred rings are five to nine membered carbocycles or heterocycles, including both cases where a portion of the ring formed by the pair of substituents is saturated and a portion of the ring formed by the pair of substituents is unsaturated. In other cases, a pair of adjacent substituents may optionally be joined or fused into a ring. As used herein, "adjacent" means that the two substituents involved may be next to each other on the same ring, or on two adjacent rings having two nearest available substitutable positions (e.g., the 2, 2' positions in biphenyl or the 1, 8 positions in naphthalene).
Layers, materials, regions, and devices may be described herein with reference to the color of light they emit. In general, as used herein, an emissive region described as producing a particular color of light may include one or more emissive layers disposed one above the other.
As used herein, a "red" layer, material, region or device refers to a layer, material, region or device that emits light in the range of about 580-700nm or whose emission spectrum in that region has the highest peak. Similarly, a "green" layer, material, region or device refers to a layer, material, region or device that emits or has an emission spectrum with a peak wavelength in the range of about 500-600 nm; "blue" layer, material or device refers to a layer, material or device that emits or has an emission spectrum with a peak wavelength in the range of about 400-500 nm; and a "yellow" layer, material, region or device refers to a layer, material, region or device having an emission spectrum with a peak wavelength in the range of about 540-600 nm. In some arrangements, respective regions, layers, materials, regions or devices may provide respective "deep blue" and "light blue" light. As used herein, in providing the respective "light blue" and "dark blue" arrangements, the "dark blue" component refers to a component having a peak emission wavelength at least about 4nm less than the peak emission wavelength of the "light blue" component. Typically, the "light blue" component has a peak emission wavelength in the range of about 465-500nm, and the "dark blue" component has a peak emission wavelength in the range of about 400-470nm, although these ranges may vary according to some configurations. Similarly, a color shifting layer refers to a layer that converts or modulates light of another color into light having a wavelength as specified for that color. For example, a "red" color filter refers to a filter that produces light having a wavelength in the range of about 580-700 nm. In general, there are two types of color shifting layers: a color filter to condition the spectrum by removing unwanted wavelengths of light, and a color shifting layer to convert higher energy photons to lower energy. "one color" component refers to a component that, when activated or in use, produces or otherwise emits light having a particular color as previously described. For example, "a first emission region of a first color" and "a second emission region of a second color different from the first color" describe two emission regions that, when activated within a device, emit two different colors as previously described.
As used herein, emissive materials, layers, and regions may be different from one another and from other structures based on the light originally produced by the materials, layers, or regions as opposed to the light ultimately emitted by the same or different structures. The initially generated light is typically the result of a change in energy level that causes photon emission. For example, an organic emissive material may initially produce blue light, which may be converted to red or green light by a color filter, quantum dot, or other structure, such that the complete emissive stack or subpixel emits red or green light. In this case, the initial emissive material or layer may be referred to as a "blue" component, even if the subpixel is a "red" or "green" component.
In some cases, it may be preferable to describe the color of components such as the emissive area, sub-pixels, color shifting layers, etc., according to 1931CIE coordinates. For example, the yellow emissive material may have a variety of peak emission wavelengths, one in or near the "green" region and one in or near the "red" region, as previously described. Accordingly, as used herein, each color item also corresponds to a shape in the 1931CIE coordinate color space. The shape in the 1931CIE color space is constructed by tracking the trajectory between two color points and any other internal points. For example, the internal shape parameters of red, green, blue, and yellow may be defined as follows:
further details regarding OLEDs and the above definitions can be found in U.S. patent No. 7,279,704, which is incorporated herein by reference in its entirety.
As disclosed herein, emissive layers or materials, such as emissive layer 135 and emissive layer 220 shown in fig. 1-2, respectively, may include quantum dots. As will be understood by those of skill in the art, unless explicitly stated to the contrary or the context indicates to the contrary, an "emissive layer" or "emissive material" as disclosed herein may include organic emissive materials and/or emissive materials containing quantum dots or equivalent structures. In general, the emissive layer comprises an emissive material within a host matrix. Such an emissive layer may comprise only quantum dot materials that convert light emitted by the respective emissive material or other emitter, or it may also comprise the respective emissive material or other emitter, or it may itself directly emit light by application of an electrical current. Similarly, color shifting layers, color filters, up-conversion or down-conversion layers or structures may include materials containing quantum dots, but such layers may not be considered "emissive layers" as disclosed herein. In general, an "emissive layer" or material is a layer or material that emits an initial light based on an injected charge, where the initial light may be altered by another layer, such as a color filter or other color changing layer that does not itself emit the initial light within the device, but may re-emit altered light of a different spectral content based on absorption and down-conversion of the initial light emitted by the emissive layer into a lower energy light emission. In some embodiments disclosed herein, the color shifting layer, color filter, up-conversion and/or down-conversion layer may be disposed external to the OLED device, such as above or below an electrode of the OLED device.
Any of the layers of the various embodiments may be deposited by any suitable method, unless otherwise specified. Preferred methods for the organic layer include thermal evaporation, ink jet (e.g., as described in U.S. Pat. nos. 6,013,982 and 6,087,196, which are incorporated herein by reference in their entirety), organic vapor deposition (OVPD) (e.g., as described in U.S. Pat. No. 6,337,102 to Forrest et al, which is incorporated herein by reference in its entirety), and deposition by organic vapor jet printing (OVJP, also known as Organic Vapor Jet Deposition (OVJD)), which is described in, e.g., U.S. Pat. No. 7,431,968, which is incorporated herein by reference in its entirety. Other suitable deposition methods include spin-coating and other solution-based processes. The solution-based process is preferably carried out under nitrogen or an inert atmosphere. For other layers, the preferred method includes thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding (e.g., as described in U.S. Pat. nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entirety), and patterning associated with some deposition methods such as inkjet and OVJP. Other methods may also be used. The material to be deposited may be modified to be compatible with the particular deposition process. For example, substituents (e.g., alkyl and aryl groups) that are branched or unbranched and preferably contain at least 3 carbons can be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3 to 20 carbons are a preferred range. Solution handleability of a material having an asymmetric structure may be better than a material having a symmetric structure because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents can be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated according to embodiments of the present disclosure may further optionally include a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damage when exposed to harmful substances in an environment including moisture, vapor, and/or gases, etc. The barrier layer may be deposited on the substrate, electrode, under or beside the substrate, electrode, or on any other portion of the device, including the edge. The barrier layer may comprise a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include a composition having a single phase as well as a composition having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate inorganic compounds or organic compounds or both. Preferred barrier layers comprise a mixture of polymeric and non-polymeric materials, as described in U.S. patent No. 7,968,146, PCT patent application No. PCT/US2007/023098, and PCT/US2009/042829, which are incorporated herein by reference in their entirety. To be considered a "mixture", the aforementioned polymeric and non-polymeric materials that make up the barrier layer should be deposited under the same reaction conditions and/or simultaneously. The weight ratio of polymeric material to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be produced from the same precursor material. In one example, the mixture of polymeric material and non-polymeric material consists essentially of polymeric silicon and inorganic silicon.
It is believed that the Internal Quantum Efficiency (IQE) of fluorescent OLEDs can exceed 25% spin statistics limits by delaying fluorescence. As used herein, there are two types of delayed fluorescence, namely P-type delayed fluorescence and E-type delayed fluorescence. The P-type delayed fluorescence is generated by triplet-triplet annihilation (TTA).
On the other hand, the E-type delayed fluorescence does not depend on the collision of two triplet states, but on the thermal population between the triplet states and the singlet excited states. Compounds capable of generating E-type delayed fluorescence must have a very small singlet-triplet gap. Thermal energy may activate a triplet transition back to a singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). A unique feature of TADF is that the delay component increases with increasing temperature due to the increase in thermal energy. If the reverse intersystem crossing rate is fast enough to minimize non-radiative decay from the triplet state, the fraction of the singlet excited state of the backfill can potentially reach 75%. The total unimodal fraction may be 100% well beyond the spin statistics limit of the electrically generated excitons.
Type E delayed fluorescence features can be found in excitation complex systems or in single compounds. Without being bound by theory, it is believed that the E-type delayed fluorescence requires a luminescent material with a small singlet-triplet energy gap (ΔES-T). This can be achieved with metal-free donor-acceptor organic luminescent materials. The emission of these materials is generally characterized by a donor-acceptor Charge Transfer (CT) type emission. The spatial separation of the HOMO and LUMO of these donor-acceptor type compounds generally results in a small Δes-T. These states may relate to CT states. Typically, donor-acceptor luminescent materials are constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) to an electron acceptor moiety (e.g., containing an N six-membered aromatic ring).
Devices made in accordance with embodiments of the present disclosure may be incorporated into a wide variety of electronic component modules (or units), which may be incorporated into a wide variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices, such as discrete light source devices or lighting panels, etc., that may be utilized by end user product manufacturers. Such electronic assembly modules may optionally include drive electronics and/or a power supply. Devices made in accordance with embodiments of the present disclosure may be incorporated into a variety of consumer products that incorporate one or more electronic component modules (or units) therein. Disclosed is a consumer product comprising an OLED comprising a compound of the present disclosure in an organic layer of the OLED. Such consumer products should include any kind of product, including one or more light sources and/or one or more visual displays of some type. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, interior or exterior lights and/or lights, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, cell phones, tablet computers, tablet phones, personal Digital Assistants (PDAs), wearable devices, notebook computers, digital cameras, video cameras, viewfinders, micro-displays with a diagonal less than 2 inches, 3-D displays, virtual or augmented reality displays, vehicles, video walls containing multiple tiled displays, theatre or gym screens, and signs. Various control mechanisms may be used to control devices manufactured in accordance with the present disclosure, including passive matrices and active matrices. Many devices are intended to be used within a temperature range that is comfortable to humans, such as 18 ℃ to 30 ℃, and more preferably at room temperature (20-25 ℃), but can be used outside this temperature range (e.g., -40 ℃ to 80 ℃).
The materials and structures described herein may be applied in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices (e.g., organic transistors) may employ the materials and structures.
In the general term in the art, a "subpixel" may refer to an emissive region that is combined with any color shifting layer, which may be a single layer EML, stacked device, or the like, that is used to adjust the color emitted by the emissive region.
As used herein, the "emissive region" of a subpixel refers to any and all emissive layers, regions, and devices in the subpixel that were originally used to generate light. The sub-pixels may also include other layers disposed in stack with the emissive region that affect the color ultimately produced by the sub-pixel, such as the color shifting layers disclosed herein, but such color shifting layers are typically not considered "emissive layers" as disclosed herein. The unfiltered sub-pixels are sub-pixels that exclude color-adjusting components (e.g., color shifting layers) but may include one or more emissive regions, layers, or devices.
In some configurations, an "emissive region" may include emissive materials that emit light of multiple colors. For example, the yellow emission region may include multiple materials that emit red and green light when each material is used alone in an OLED device. When used in a yellow device, the individual materials are typically not arranged such that they can be individually activated or addressed. That is, a "yellow" OLED stack containing the material cannot be driven to produce red, green, or yellow light; in practice, the stack as a whole may be driven to produce yellow light. Such an emission region may be referred to as a yellow emission region, although at the level of the individual emitters, the stack does not directly produce yellow light. As described in more detail below, the individual emissive materials used in the emissive regions (if more than one) may be placed in the same emissive layer within the device, or in multiple emissive layers within an OLED device that includes the emissive regions. As described in more detail below, embodiments disclosed herein may provide an OLED device (e.g., a display) that includes a limited number of colors of an emission region while including sub-pixels or other OLED devices that have a greater number of colors than the number of colors of the emission region. For example, a device as disclosed herein may include only blue and yellow emission regions. Other colors of subpixels may be achieved by using color shifting layers (e.g., disposed in stacks with yellow or blue emitting regions), or more generally, by using color shifting layers, electrodes, or other structures forming microcavities as disclosed herein, or any other suitable configuration. In some cases, the general color provided by the sub-pixels may be the same as the color provided by the emissive regions in the stack defining the sub-pixels, e.g., with a deep blue color-changing layer disposed stacked with the light blue emissive regions to create a deep blue sub-pixel. Similarly, the color provided by the sub-pixels may be different from the color provided by the emissive regions in the stack defining the sub-pixels, for example where a green color-changing layer is disposed stacked with the yellow emissive regions to create a green sub-pixel.
In some configurations, the emissive region and/or emissive layer may span multiple sub-pixels, for example, where fabrication of other layers and circuitry may allow the emissive region or portions of the layers to be individually addressable.
The emissive region as disclosed herein may be different from the emissive "layer" typically referred to in the art and used herein. In some cases, a single emission region may include multiple layers, for example, where the yellow emission region is made by sequentially forming red and green emission layers into the yellow emission region. As previously described, when such layers are present in an emissive region as disclosed herein, the layers are not individually addressable within a single emissive stack; in effect, the layers are activated or driven in parallel for the emissive region to produce light of the desired color. In other configurations, the emissive region may comprise a single emissive layer having a single color, or multiple emissive layers having the same color, in which case the color of such emissive layers would be the same as the color of the emissive region in which the emissive layer is disposed, or within the same spectral interval as the color of the emissive region in which the emissive layer is disposed.
B. OLED and device of the present disclosure
In one aspect, the present disclosure provides an Organic Light Emitting Device (OLED) comprising:
An anode;
A cathode; and
An emissive region disposed between the anode and the cathode;
wherein the emission area comprises:
compound S1;
A compound A1;
Compound S2; and
Compound A2;
wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2;
Wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter;
wherein the compound S1 may be the same as or different from the compound S2;
Wherein the compound A1 may be the same as or different from the compound A2; and
And wherein at least one of the following conditions holds:
(1) The compound S1 is different from the compound S2;
(2) The compound A1 is different from the compound A2.
In some embodiments, compound S1 is the same as compound S2. In some embodiments, compound S1 is different from compound S2. In some embodiments, compound A1 is the same as compound A2. In some embodiments, compound A1 is different from compound A2.
In some embodiments, each of compounds S1 and S2 is independently capable of acting as a phosphorescent emitter in an OLED at room temperature. In some embodiments, each of compounds S1 and S2 is independently capable of acting as a TADF emitter in an OLED at room temperature. In some embodiments, each of compounds S1 and S2 is independently capable of acting as a dual state emitter in an OLED at room temperature.
In some embodiments, each of compounds A1 and A2 is independently selected from the group consisting of: a delayed fluorescent compound acting as TADF emitter in an OLED at room temperature, a fluorescent compound acting as a fluorescent emitter in said OLED at room temperature. In some embodiments, the fluorescent emitter may be a singlet or a doublet emitter. In some such embodiments, the singlet emitter may also comprise a TADF emitter.
As used herein, there are two types of delayed fluorescence, namely P-type delayed fluorescence and E-type delayed fluorescence. The P-type delayed fluorescence is generated by triplet-triplet annihilation (TTA).
On the other hand, the E-type delayed fluorescence does not depend on the collision of two triplet states, but on the number of thermal population between triplet and singlet excited states (thermal population). Compounds capable of generating E-type delayed fluorescence are needed to have a small singlet-triplet gap. Thermal energy may activate a triplet transition back to a singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). One significant feature of TADF is that the delay component increases with increasing temperature due to increasing thermal energy. In an electroluminescent device featuring TADF emitters, 75% of the electrically generated excitons are triplet excitons. If the rate of intersystem crossing in the reverse direction is fast enough to minimize non-radiative decay from the triplet state, the fraction of singlet excited states that are back-populated can potentially reach 75%, which would be the fraction of triplet excitons that are all electrically generated. The total singlet fraction may be 100%, well beyond the spin statistical limit for electrically generated excitons.
The type E delayed fluorescence feature may be found in an exciplex system or in a single compound. Without being bound by theory, it is believed that the E-type delayed fluorescence requires a luminescent material with a small singlet-triplet energy gap (ΔES-T). This can be achieved with metal-free donor-acceptor organic luminescent materials. The emission of these materials is typically characterized as donor-acceptor Charge Transfer (CT) type emission. The spatial separation of HOMO from LUMO in these donor-acceptor type compounds generally results in a small Δes-T. These states may relate to CT states. Typically, donor-acceptor luminescent materials are constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) to an electron acceptor moiety (e.g., an N-containing six-membered aromatic ring).
In some embodiments, at least two of compounds S1, S2, A1, and A2 are in separate layers within the emissive region.
In some embodiments, at least one of compounds S1 and S2 is in one layer within the emission region, and compounds A1 and A2 are mixed together in separate layers within the emission region.
In some embodiments, compound S1 and compound A1 are mixed together in one layer within the emission region; and compound S2 and compound A2 are mixed together in separate layers within the emission area.
In some embodiments, compounds S1, S2, A1, and A2 are all in layers that are separate from each other within the emissive region. In some embodiments, the above-described individual layers containing compounds S1, S2, A1, and A2 are in contact with each other.
In some embodiments, compounds S1, S2, A1, and A2 are present in a mixture in one layer in the emissive region. It should be understood that the mixture may be a homogeneous mixture, or the compounds in the mixture may be present in a gradient concentration throughout the thickness of the layer. The concentration gradient may be linear, non-linear, sinusoidal, etc. In addition to compounds S1, S2, A1 and A2, one or more other functional compounds may be present, such as, but not limited to, a host, also mixed into the mixture.
In some embodiments, the emissive region contains N layers, and N >2.
In some embodiments, at least one of the following conditions holds: (1) Compound S1 is contained in each of the N layers, and compound A1 is contained in N-1 layers or less; (2) The compound S2 being contained in each of the N layers, the compound A2 being contained in less than or equal to N-1 layers
In some embodiments, at least one of compounds A1 and A2 is contained within less than or equal to N/2 layers.
In some embodiments, at least one of compounds A1 and A2 is in a separate layer with S1 and S2 compounds.
In some embodiments, the layer containing at least one of compounds A1 and A2 comprises another compound that is not contained in the layer having S1 and S2 compounds.
In some embodiments, two or more layers contain at least one of compounds A1 and A2; wherein the concentration of at least one of compounds A1 and A2 in at least two of the two or more layers is different.
In some embodiments, when a voltage is applied across the OLED, the OLED emits a luminescent emission comprising an emission component of S 1 energy from compound A1 or A2.
In some embodiments, when a voltage is applied across the OLED, the OLED emits a luminescent emission comprising an emission component of S 1 energy from compounds A1 and A2.
In some embodiments, at least 65% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 10cd/m 2. In some embodiments, at least 65% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 1000cd/m 2. In some embodiments, at least 75% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 10cd/m 2. In some embodiments, at least 75% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 1000cd/m 2. In some embodiments, at least 85% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 10cd/m 2. In some embodiments, at least 85% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 1000cd/m 2. In some embodiments, at least 95% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 10cd/m 2. In some embodiments, at least 95% of the emission of the OLED is produced by compounds A1 and A2 at a luminance of at least 1000cd/m 2.
In some embodiments, the S 1 energy of the A1 and A2 compounds is each lower than the S 1 energy of each of the compounds S1 and S2.
In some embodiments, the S 1-T1 energy gap of compound S1 is less than 400meV. In some embodiments, the S 1-T1 energy gap of compound S1 is less than 300meV. In some embodiments, the S 1-T1 energy gap of compound S1 is less than 250meV. In some embodiments, the S 1-T1 energy gap of compound S1 is less than 200meV. In some embodiments, the S 1-T1 energy gap of compound S1 is less than 150meV. In some embodiments, the S 1-T1 energy gap of compound S1 is less than 100meV. In some embodiments, the S 1-T1 energy gap of compound S1 is less than 50meV.
In some embodiments, the S 1-T1 energy gap of compound S2 is less than 400meV. In some embodiments, the S 1-T1 energy gap of compound S2 is less than 300meV. In some embodiments, the S 1-T1 energy gap of compound S2 is less than 250meV. In some embodiments, the S 1-T1 energy gap of compound S2 is less than 200meV. In some embodiments, the S 1-T1 energy gap of compound S2 is less than 150meV. In some embodiments, the S 1-T1 energy gap of compound S2 is less than 100meV. In some embodiments, the S 1-T1 energy gap of compound S2 is less than 50meV.
In some embodiments, the S 1-T1 energy gap of compound A1 is less than 400meV. In some embodiments, the S 1-T1 energy gap of compound A1 is less than 300meV. In some embodiments, the S 1-T1 energy gap of compound A1 is less than 250meV. In some embodiments, the S 1-T1 energy gap of compound A1 is less than 200meV. In some embodiments, the S 1-T1 energy gap of compound A1 is less than 150meV. In some embodiments, the S 1-T1 energy gap of compound A1 is less than 100meV. In some embodiments, the S 1-T1 energy gap of compound A1 is less than 50meV.
In some embodiments, the S 1-T1 energy gap of compound A2 is less than 400meV. In some embodiments, the S 1-T1 energy gap of compound A2 is less than 300meV. In some embodiments, the S 1-T1 energy gap of compound A2 is less than 250meV. In some embodiments, the S 1-T1 energy gap of compound A2 is less than 200meV. In some embodiments, the S 1-T1 energy gap of compound A2 is less than 150meV. In some embodiments, the S 1-T1 energy gap of compound A2 is less than 100meV. In some embodiments, the S 1-T1 energy gap of compound A2 is less than 50meV.
In some embodiments, the stokes shift for compound A1 is 30nm or less. In some embodiments, the stokes shift for compound A1 is 25nm or less. In some embodiments, the stokes shift for compound A1 is 20nm or less. In some embodiments, the stokes shift for compound A1 is 15nm or less. In some embodiments, the stokes shift for compound A1 is 10nm or less.
In some embodiments, the stokes shift for compound A1 is 30nm or more. In some embodiments, the stokes shift for compound A1 is 40nm or more. In some embodiments, the stokes shift for compound A1 is 60nm or more. In some embodiments, the stokes shift for compound A1 is 80nm or more. In some embodiments, the stokes shift for compound A1 is 100nm or more.
In some embodiments, the stokes shift for compound A2 is 30nm or less. In some embodiments, the stokes shift for compound A2 is 25nm or less. In some embodiments, the stokes shift for compound A2 is 20nm or less. In some embodiments, the stokes shift for compound A2 is 15nm or less. In some embodiments, the stokes shift for compound A2 is 10nm or less.
In some embodiments, the stokes shift for compound A2 is 30nm or more. In some embodiments, the stokes shift for compound A2 is 40nm or more. In some embodiments, the stokes shift for compound A2 is 60nm or more. In some embodiments, the stokes shift for compound A2 is 80nm or more. In some embodiments, the stokes shift for compound A2 is 100nm or more.
In some embodiments, the stokes shift for each of compounds A1 and A2 is 30nm or higher. In some embodiments, the stokes shift for each of compounds A1 and A2 is 40nm or higher. In some embodiments, each of compounds A1 and A2 has a stokes shift of 60nm or more. In some embodiments, each of compounds A1 and A2 has a stokes shift of 80nm or more. In some embodiments, the stokes shift for each of compounds A1 and A2 is 100nm or higher.
In some embodiments, the stokes shift for compound A1 differs from the stokes shift for compound A2 by at least 20nm. In some embodiments, the stokes shift for compound A1 differs from the stokes shift for compound A2 by at least 40nm. In some embodiments, the stokes shift for compound A1 differs from the stokes shift for compound A2 by at least 60nm. In some embodiments, the stokes shift for compound A1 differs from the stokes shift for compound A2 by at least 80nm. In some embodiments, the stokes shift for compound A1 differs from the stokes shift for compound A2 by at least 100nm.
In some embodiments, compound S1 has an emission maximum of lambda max1 in a single-color OLED with a host at room temperature; wherein by replacing compound S1 with compound A1, compound A1 has an emission maximum of lambda max2 in the single-color OLED; wherein Δλ=λ max1-λmax2; and wherein Δλ is equal to or less than a number selected from the group consisting of: 15. 12, 10, 8, 6, 4, 2, 0, -2, -4, -6, -8 and-10 nm.
In some embodiments, compound S2 has an emission maximum of lambda max1 in a single-color OLED with a host at room temperature; wherein by replacing compound S2 with compound A2, compound A2 has an emission maximum of lambda max3 in the single-color OLED; wherein Δλ=λ max1-λmax3; and wherein Δλ is equal to or less than a number selected from the group consisting of: 15. 12, 10, 8, 6, 4, 2, 0, -2, -4, -6, -8 and-10 nm.
In some embodiments, compound S1 has an emission maximum of lambda max1 in a single-color OLED with a host at room temperature; wherein by replacing compound S1 with compound A1, compound A1 has an emission maximum of lambda max2 in the single-color OLED; wherein Δλ=λ max1-λmax2; and wherein Δλ is equal to or greater than a number selected from the group consisting of: 20. 30, 40, 60, 80, 100nm.
In some embodiments, compound S2 has an emission maximum of lambda max1 in a single-color OLED with a host at room temperature; wherein by replacing compound S2 with compound A2, compound A2 has an emission maximum of lambda max3 in the single-color OLED; wherein Δλ=λ max1-λmax3; and wherein Δλ is equal to or greater than a number selected from the group consisting of: 20. 30, 40, 60, 80, 100nm.
In some embodiments, at least one of compounds S1 and S2 is capable of acting as a phosphorescent emitter in an OLED at room temperature. In some embodiments, at least one of compounds S1 and S2 is capable of emitting light from a triplet excited state to a singlet ground state at room temperature in an OLED.
In some embodiments, at least one of compounds S1 and S2 is a metal coordination complex having a metal-carbon bond.
In some embodiments, at least one of compounds S1 and S2 is a metal coordination complex having a metal-nitrogen bond.
In some embodiments, at least one of compounds S1 and S2 is a metal coordination complex having a metal-oxygen bond.
In some embodiments, the metal is selected from the group consisting of: ir, rh, re, ru, os, pt, zn, zr, au, ag and Cu.
In some embodiments, the metal is Ir. In some embodiments, the metal is Pt.
In some embodiments, at least one of compounds S1 and S2 has formula M (L 1)x(L2)y(L3)z;
Wherein L 1、L2 and L 3 may be the same or different;
wherein x is 1, 2 or 3;
wherein y is 0,1 or 2;
wherein z is 0,1 or 2;
where x+y+z is the oxidation state of the metal M,
Wherein L 1 is selected from the group consisting of:
Wherein L 2 and L 3 are independently selected from the group consisting of:
wherein T is selected from the group consisting of B, al, ga, and In;
Wherein K 1' is a direct bond or is selected from the group consisting of: NR e、PRe, O, S and Se;
Wherein each Y 1 to Y 13 is independently selected from the group consisting of carbon and nitrogen;
wherein Y' is selected from the group consisting of :BRe、NRe、PRe、O、S、Se、C=O、S=O、SO2、CReRf、SiReRf and der eRf;
R e and R f may be fused or joined to form a ring;
Wherein each R a、Rb、Rc and R d may independently represent mono-substitution to the maximum number of substitutions or no substitution possible;
Wherein each R a1、Rb1、Rc1、Rd1、Ra、Rb、Rc、Rd、Re and R f is independently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; and
Wherein any two of R a1、Rb1、Rc1、Rd1、Ra、Rb、Rc and R d may be fused or joined to form a ring or to form a multidentate ligand.
In some embodiments, the metal in formula M (L 1)x(L2)y(L3)z) is selected from the group consisting of Cu, ag, or Au.
In some embodiments, at least one of compounds S1 and S2 has formulas :Ir(LA)3、Ir(LA)(LB)2、Ir(LA)2(LB)、Ir(LA)2(LC)、Ir(LA)(LB)(LC) and Pt (L A)(LB) selected from the group consisting of;
Wherein L A、LB and L C are different from each other in the Ir compound;
Wherein L A and L B may be the same or different in the Pt compound; and
Wherein L A and L B can be linked to form a tetradentate ligand in the Pt compound.
In some embodiments, at least one of compounds S1 and S2 comprises at least one electron withdrawing group. In some such embodiments, the electron withdrawing group generally comprises one or more highly electronegative elements including, but not limited to, fluorine, oxygen, sulfur, nitrogen, chlorine, and bromine. In some such embodiments, the electron withdrawing group has a Hammett constant (Hammett constant) greater than 0. In some such embodiments, the Hammett constant of the electron withdrawing group is equal to or greater than 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, or 1.1.
In some such embodiments, the electron withdrawing group is selected from the group :F、CF3、CN、COCH3、CHO、COCF3、COOMe、COOCF3、NO2、SF3、SiF3、PF4、SF5、OCF3、SCF3、SeCF3、SOCF3、SeOCF3、SO2F、SO2CF3、SeO2CF3、OSeO2CF3、OCN、SCN、SeCN、NC、+N(Rk2)3、(Rk2)2CCN、(Rk2)2CCF3、CNC(CF3)2、BRk3Rk2、 consisting of substituted or unsubstituted dibenzoborole, 1-substituted carbazole, 1, 9-substituted carbazole, substituted or unsubstituted pyridine, substituted or unsubstituted pyrimidine, substituted or unsubstituted pyrazine, substituted or unsubstituted pyridoxine, substituted or unsubstituted triazine, substituted or unsubstituted oxazole, substituted or unsubstituted benzoxazole, substituted or unsubstituted thiazole, substituted or unsubstituted benzothiazole, substituted or unsubstituted imidazole, substituted or unsubstituted benzimidazole, ketone, carboxylic acid, ester, nitrile, isonitrile, sulfinyl, sulfonyl, partially and fully fluorinated alkyl, partially and fully fluorinated aryl, partially and fully fluorinated heteroaryl, cyano-containing alkyl, cyano-containing heteroaryl, isocyanate
Wherein Y G is selected from the group consisting of :BRe、NRe、PRe、O、S、Se、C=O、S=O、SO2、CReRf、SiReRf and der eRf; and
R k1 each independently represents mono-substitution to the maximum allowable substitution or no substitution;
Wherein each of R k1、Rk2、Rk3、Re and R f is independently hydrogen or a substituent selected from the group consisting of the general substituents defined herein.
In some embodiments, at least one of compounds S1 and S2 is selected from the group consisting of the compounds in the following sensitizer list:
Each of X 96 to X 99 is independently C or N;
Each Y 100 is independently selected from the group consisting of NR ", O, S and Se;
L is independently selected from the group consisting of: direct bond, BR "R '", NR ", PR", O, S, se, C = O, C = S, C =se, c=nr ", c=cr" R ' ", s= O, SO 2, CR" R ' ", siR" R ' ", ger" R ' ", alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof;
X 100 and X 200 are selected at each occurrence from the group consisting of O, S, se, NR ' and CR ' R ';
each of R 10a、R20a、R30a、R40a and R 50a、RA"、RB"、RC"、RD"、RE" and R F" independently represents mono-to maximum substitution or no substitution;
R、R'、R"、R"'、R10a、R11a、R12a、R13a、R20a、R30a、R40a、R50a、R60、R70、R97、R98、R99、RA1'、RA2'、RA"、RB"、RC"、RD"、RE"、RF"、RG"、RH"、RI"、RJ"、RK"、RL"、RM" And each of R N "is independently hydrogen or a substituent selected from the group consisting of the general substituents as defined herein; wherein any two substituents may be fused or joined to form a ring.
In some of the above embodiments at least one of ,R、R'、R"、R"'、R10a、R11a、R12a、R13a、R20a、R30a、R40a、R50a、R60、R70、R97、R98、R99、RA1'、RA2'、RA"、RB"、RC"、RD"、RE"、RF"、RG"、RH"、RI"、RJ"、RK"、RL"、RM" and R N" comprises or is an electron withdrawing group as defined herein.
In some of the above embodiments wherein at least one of S1 and S2 is selected from the group consisting of structures in the sensitizer list, one or more of ,R、R'、R"、R"'、R10a、R11a、R12a、R13a、R20a、R30a、R40a、R50a、R60、R70、R97、R98、R99、RA1'、RA2'、RA"、RB"、RC"、RD"、RE"、RF"、RG"、RH"、RI"、RJ"、RK"、RL"、RM" and R N" comprises a portion selected from the group consisting of: fully or partially deuterated aryl, fully or partially deuterated alkyl, borane, silane, germane, 2, 6-diphenyl, 2- (t-butyl) phenyl, tetraphenyl, tetrahydronaphthalene, and combinations thereof.
It will be appreciated that the metallic Pt in each of those compounds in the sensitizer list may be replaced by Pd, and that it is also desirable to specifically encompass those derived Pd compounds.
In some embodiments, the sensitizer is capable of acting as a phosphorescent emitter, TADF emitter, or dual state emitter in an OLED at room temperature. In some embodiments, the receptor is selected from the group consisting of: a delayed fluorescent compound that acts as a TADF emitter in an OLED at room temperature, a fluorescent compound that acts as a fluorescent emitter in an OLED at room temperature. In some embodiments, the fluorescent emitter may be a singlet or a doublet emitter. In some such embodiments, the singlet emitter may also comprise a TADF emitter, and in addition, a multi-resonant MR-TADF emitter. As used herein, a description of delayed fluorescence may be found in U.S. application publication No. US20200373510A1 paragraphs 0083-0084, the entire contents of which are incorporated herein by reference.
In some embodiments of OLEDs, the sensitizer and acceptor are present in separate layers within the emissive region.
In some embodiments, the sensitizer and acceptor are present in a mixture in one or more layers in the emissive region. It should be understood that the mixture in a given layer may be a homogeneous mixture, or the compounds in the mixture may have a concentration gradient throughout the thickness of the given layer. The concentration gradient may be linear, non-linear, sinusoidal, etc. When more than one layer is present in the emissive region having a mixture of sensitizer and acceptor compound, the type of mixture (i.e., homogeneous or gradient concentration) and the concentration level of compound in the mixture in each of the more than one layers may be the same or different. In addition to the sensitizer and acceptor compounds, one or more other functional compounds may be present, such as, but not limited to, host, also mixed into a mixture.
In some embodiments, the acceptor compound may be present in two or more layers having the same or different concentrations. In some embodiments, when two or more layers contain the acceptor compound, the concentration of the acceptor compound in at least two of the two or more layers is different. In some embodiments, the concentration of sensitizer compound in the layer containing sensitizer compound is in the range of 1 to 50 weight percent, 10 to 20 weight percent, or 12 to 15 weight percent. In some embodiments, the concentration of the acceptor compound in the layer containing the acceptor compound is in the range of 0.1 to 10 wt%, 0.5 to 5 wt%, or 1 to 3 wt%.
In some embodiments, the emissive region contains N layers, where N >2. In some embodiments, the sensitizer is present in each of the N layers and the acceptor is contained in less than or equal to N-1 layers. In some embodiments, the sensitizer is present in each of the N layers and the acceptor is contained in less than or equal to N/2 layers. In some embodiments, the receptor is present in each of the N layers and the sensitizer is contained in less than or equal to N-1 layers. In some embodiments, the receptor is present in each of the N layers and the sensitizer is contained in less than or equal to N/2 layers.
In some embodiments, when a voltage is applied across the OLED, the OLED emits a luminescent emission that includes an emission component of S 1 energy (first singlet energy) from the acceptor. In some embodiments, at least 65%, 75%, 85%, or 95% of the emission of the OLED is produced by the acceptor at a luminance of at least 10cd/m 2. In some embodiments, the S 1 energy of the acceptor is lower than the S 1 energy of the sensitizer.
In some embodiments, the T 1 energy (first triplet energy) of the host compound is greater than or equal to the T 1 energy of the sensitizer and the acceptor, and the T 1 energy of the sensitizer is greater than or equal to the S 1 energy (first singlet energy) of the acceptor. In some embodiments, the S 1-T1 energy gap of the sensitizer and/or acceptor and/or first host compound and/or second host compound is less than 400, 300, 250, 200, 150, 100, or 50meV. In some embodiments, the absolute energy difference between the HOMO of the sensitizer and the HOMO of the acceptor is less than 0.6, 0.5, 0.4, 0.3, or 0.2eV. In some embodiments, the absolute energy difference between the LUMO of the sensitizer and the LUMO of the acceptor is less than 0.6, 0.5, 0.4, 0.3, or 0.2eV.
In some embodiments where the sensitizer provides monochromatic sensitization (i.e., minimal energy loss after energy transfer to the receptor), the receptor has a Stokes shift (Stokes shift) of 30, 25, 20, 15, or 10nm or less. Examples are broad blue phosphors sensitive to narrow blue light emitting receptors.
In some embodiments where the sensitizer provides a down-conversion process (e.g., a blue emitter for sensitizing a green emitter, or a green emitter for sensitizing a red emitter), the receptor has a stokes shift of 30, 40, 60, 80, or 100nm or more.
In some embodiments, the difference between the λmax of the sensitizer emission spectrum and the λmax of the acceptor absorption spectrum is 50, 40, 30, or 20nm or less. In some embodiments, the light absorption area of the acceptor overlaps the light emitting area of the sensitizer by more than 5%, 10%, 15%, 20%, 30%, 40%, 50% or more relative to the light emitting area of the sensitizer.
One way to quantify the qualitative relationship between sensitizer compounds (compounds to be used as sensitizers in the OLED emission regions of the present disclosure) and acceptor compounds (compounds to be used as acceptors in the OLED emission regions of the present disclosure) is the measurement Δλ=λ max1-λmax2, where λ max1 and λ max2 are defined as follows. Lambda max1 is the maximum emission of the sensitizer compound at room temperature when it is used as the sole emitter in a first monochromatic OLED (OLED emitting only one color) with a first host. Lambda max2 is the maximum emission of the acceptor compound at room temperature when the acceptor compound is used as the sole emitter in a second monochromatic OLED with the same first host.
In some embodiments of the disclosed OLED in which the sensitizer provides monochromatic sensitization (i.e., minimal energy loss after energy transfer to the receptor), Δλ (measured as described above) is equal to or less than a number selected from the group consisting of: 15. 12, 10, 8, 6, 4, 2, 0, -2, -4, -6, -8 and-10 nm.
In some embodiments, the spectral overlap integral of sensitizer and acceptor is at least 10 14nm4* L/cm. In some embodiments, the spectral overlap integral of sensitizer and acceptor is at least 5x 10 14nm4* L/cm x mol. In some embodiments, the spectral overlap integral of sensitizer and acceptor is at least 10 15nm4* L/cm.
As used herein, "spectral overlap integration" is determined by multiplying the acceptor extinction spectrum by the sensitizer emission spectrum normalized to the area under the curve. The higher the spectral overlap, the more fosterThe better the resonance energy transfer (FRET) efficiency. FRET ratio is proportional to spectral overlap integral. Thus, the hyperspectral overlap can help to improve FRET efficiency and shorten exciton lifetime in an OLED.
In some embodiments, to increase spectral overlap, the receptor and sensitizer are selected. The increase in spectral overlap can be achieved in several ways, such as increasing the oscillation intensity of the receptor, minimizing the distance between the peak emission intensity of the sensitizer and the peak absorption of the receptor, and narrowing the linear shape of the sensitizer emission or receptor absorption. In some embodiments, the oscillation intensity of the receptor is greater than or equal to 0.1.
In some embodiments where the receptor emission is red shifted by sensitization, the absolute value of Δλ is equal to or greater than a value selected from the group consisting of 20, 30, 40, 60, 80, 100nm.
In some embodiments, the sensitizer and/or acceptor may be a phosphorescent or fluorescent emitter. Phosphorescence generally refers to photon emission as the number of electron spin quanta changes, i.e., the initial and final states of emission have different numbers of electron spin quanta, e.g., from the T1 to S0 states. Ir and Pt complexes currently widely used in OLEDs belong to the phosphorescent emitters. In some embodiments, if excitation complex formation involves triplet emitters, such excitation complexes may also emit phosphorescence. Fluorescent emitters, on the other hand, generally refer to photon emissions with unchanged electron spin quantum numbers, e.g., from the S1 to S0 state, or from the D1 to D0 state. The fluorescent emitter may be a delayed fluorescent or non-delayed fluorescent emitter. Depending on the spin state, the fluorescent emitter may be a singlet emitter or a doublet emitter or other multiple state emitter. It is believed that the Internal Quantum Efficiency (IQE) of fluorescent OLEDs can exceed 25% spin statistics limits by delaying fluorescence. There are two types of delayed fluorescence, namely P-type and E-type delayed fluorescence. The P-type delayed fluorescence is generated by triplet-triplet annihilation (TTA). On the other hand, the E-type delayed fluorescence does not depend on the collision of two triplet states, but on the thermal population between the triplet states and the singlet excited states. Thermal energy may activate a triplet transition back to a singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). Type E delayed fluorescence features can be found in excitation complex systems or in single compounds. Without being bound by theory, it is believed that TADF requires that the compound or the excitation complex have a small singlet-triplet energy gap (Δe S-T) of less than or equal to 400, 350, 300, 250, 200, 150, 100, or 50 meV. There are two main types of TADF emitters, one is known as donor-acceptor TADF and the other is known as Multiple Resonance (MR) TADF. Typically, a donor-acceptor single compound is constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) and an electron acceptor moiety (e.g., containing an N six-membered aromatic ring). A donor-acceptor excitation complex may be formed between the hole transporting compound and the electron transporting compound. Examples of MR-TADF include highly conjugated fused ring systems. In some embodiments, the MR-TADF material contains boron, carbon and nitrogen atoms. It may also contain other atoms, such as oxygen. In some embodiments, the delayed fluorescence emission has a reverse intersystem crossing time from T1 to S1 at 293K of less than or equal to 10 microseconds. In some embodiments, such time may be greater than 10 microseconds and less than 100 microseconds.
In some embodiments, at least one of the following conditions holds:
(1) At least one of the compounds S1 and S2 is capable of acting as TADF emitter in an OLED at room temperature,
(2) At least one of compounds A1 and A2 is a delayed fluorescence compound that acts as TADF emitter in the OLED at room temperature.
In some embodiments, the TADF emitter comprises at least one donor group and at least one acceptor group. In some embodiments, the TADF emitter is a metal complex. In some embodiments, the TADF emitter is a nonmetallic complex. In some embodiments, the TADF emitter is a boron-containing compound. In some embodiments, the TADF emitter is Cu, zn, zr, ag or an Au complex.
In some embodiments of the OLED, the TADF emitter has the formula M (L 5)(L6), wherein M is Cu, ag or Au, L 5 and L 6 are different, and L 5 and L 6 are independently selected from the group consisting of:
wherein each a 1-A9 is independently selected from C or N;
Each R P、RQ and R U independently represents mono-substitution up to maximum substitution or no substitution; wherein each RP、RP、RU、RSA、RSB、RRA、RRB、RRC、RRD、RRE and R RF is independently hydrogen or a substituent selected from the group consisting of universal substituents as defined herein; any two substituents may be joined or fused to form a ring.
In some embodiments of the OLED, the TADF emitter may be one of the following:
Wherein each R A"、RB"、RC"、RD"、RE" and R F" may independently represent a single to the maximum possible number of substitutions or no substitutions;
Each R ", R'", R A1、RA"、RB"、RC"、RD"、RE" and R F" is independently hydrogen or a substituent selected from the group consisting of universal substituents as defined herein; wherein any two substituents may be fused or joined to form a ring.
Wherein L is independently selected from the group consisting of: direct bond, BR "R '", NR ", PR", O, S, se, C = O, C = S, C =se, c=nr ", c=cr" R ' ", s= O, SO 2, CR" R ' ", siR" R ' ", ger" R ' ", alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof;
Wherein each of L 1 'and L 2' is a monodentate anionic ligand,
Wherein each of X 1 'and X 2' is halo; and
Wherein any two substituents may be joined or fused to form a ring.
In some embodiments of the OLED, the TADF emitter is selected from the group consisting of:
in some embodiments of the OLED, the TADF emitter comprises boron atoms. In some embodiments, the TADF emitter comprises at least one chemical moiety selected from the group consisting of:
wherein Y T、YU、YV and Y W are each independently selected from the group consisting of: BR, NR, PR, O, S, se, C = O, S = O, SO 2, BRR ', CRR', siRR 'and GeRR';
Wherein each R T may be the same or different and each R T is independently a donor, an acceptor group, an organic linking group bonded to the donor, an organic linking group bonded to the acceptor group, or an end group selected from the group consisting of: alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, aryl, heteroaryl, and combinations thereof; and
R and R' are each independently hydrogen or a substituent selected from the group consisting of the universal substituents defined herein.
In some of the above embodiments, any up to a total of three carbon ring atoms in each benzene ring of any of the above structures, together with their substituents, may be replaced with N.
In some embodiments, the TADF emitter comprises at least one acceptor moiety selected from the group consisting of: nitrile, isonitrile, borane, fluoro, pyridine, pyrimidine, pyrazine, triazine, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-triphenylene, imidazole, pyrazole, oxazole, thiazole, isoxazole, isothiazole, triazole, thiadiazole, and oxadiazole. In some embodiments, the acceptor moiety and the donor moiety as described herein can be directly attached via a conjugated linking group or a non-conjugated linking group (e.g., sp3 carbon or silicon atom).
In some embodiments, at least one of the following conditions holds:
(1) One of compounds A1 and A2 is a fluorescent compound that acts as an emitter in the OLED at room temperature;
(2) Each of compounds A1 and A2 is independently a fluorescent compound that acts as an emitter in the OLED at room temperature;
Wherein the fluorescent compound comprises at least one chemical moiety selected from the group consisting of:
wherein Y F、YG、YH and Y I are each independently selected from the group consisting of: BR, NR, PR, O, S, se, C = O, S = O, SO 2, BRR ', CRR', siRR 'and GeRR';
Wherein X F and Y G are each independently selected from the group consisting of C and N; and
Wherein R F、RG, R, and R' are each independently hydrogen or a substituent selected from the group consisting of the universal substituents defined herein.
In some of the above embodiments, any carbon ring atom up to a maximum total of three in each phenyl ring in any of the above structures, along with its substituents, may be substituted with N.
In some embodiments, at least one of the following conditions holds:
(1) One of compounds A1 and A2 is a fluorescent compound that acts as an emitter in the OLED at room temperature;
(2) Each of compounds A1 and A2 is independently a fluorescent compound that acts as an emitter in the OLED at room temperature;
Wherein the fluorescent compound is selected from the group consisting of:
Wherein Y F1 to Y F4 are each independently selected from O, S and NR F1
Wherein R F1 and R 1 to R 9 each independently represent a single substitution to the maximum possible number of substitutions or no substitution; and
Wherein R F1 and R 1 to R 9 are each independently hydrogen or a substituent selected from the group consisting of general substituents as defined herein, and any two substituents may join or fuse to form a ring.
In some of the above embodiments, any up to a total of three carbon ring atoms in each benzene ring of any of the above structures, together with their substituents, may be replaced with N.
In some embodiments, compound A1 comprises a fused ring system having at least five 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A1 comprises a fused ring system having at least six 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A1 comprises a fused ring system having at least seven 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A1 comprises a fused ring system having at least eight 5-and/or 6-membered aromatic rings. In some embodiments, compound A1 comprises a fused ring system having at least nine 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A1 comprises a fused ring system having at least ten 5-membered and/or 6-membered aromatic rings.
In some embodiments, compound A2 comprises a fused ring system having at least five 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A2 comprises a fused ring system having at least six 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A2 comprises a fused ring system having at least seven 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A2 comprises a fused ring system having at least eight 5-and/or 6-membered aromatic rings. In some embodiments, compound A2 comprises a fused ring system having at least nine 5-membered and/or 6-membered aromatic rings. In some embodiments, compound A2 comprises a fused ring system having at least ten 5-membered and/or 6-membered aromatic rings.
In some embodiments, compound A1 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 80% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 80% of the population of the lowest triplet excited state is localized in the second group. In some embodiments, compound A1 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 85% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 85% of the population of the lowest triplet excited state is localized in the second group. In some embodiments, compound A1 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 90% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 90% of the population of the lowest triplet excited state is localized in the second group. In some embodiments, compound A1 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 95% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 95% of the population of the lowest triplet excited state is localized in the second group.
In some embodiments, compound A2 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 80% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 80% of the population of the lowest triplet excited state is localized in the second group. In some embodiments, compound A2 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 85% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 85% of the population of the lowest triplet excited state is localized in the second group. In some embodiments, compound A2 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 90% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 90% of the population of the lowest triplet excited state is localized in the second group. In some embodiments, compound A2 has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 95% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 95% of the population of the lowest triplet excited state is localized in the second group.
In some embodiments, the receptor compound may be selected from the group consisting of structures in the following list of receptors:
an aza-substituted variant thereof, a fully or partially deuterated variant thereof, and combinations thereof.
In some of the above embodiments, any up to a total of three carbon ring atoms in each benzene ring of any of the above structures, together with their substituents, may be replaced with N.
In some embodiments, the receptor comprises a fused ring system having at least five to fifteen 5-membered and/or 6-membered aromatic rings. In some embodiments, the acceptor compound has a first group and a second group, wherein the first group and the second group do not overlap; wherein at least 80% of the population of singlet excited states of the lowest singlet excited states is localized in the first group; and wherein at least 80%, 85%, 90% or 95% of the population of the lowest triplet excited state is localized in the second group.
In some embodiments, the emission region further includes a first body. In some embodiments, at least one of the S1 and S2 compounds forms an exciplex with the first host in the OLED at room temperature. In some embodiments, the LUMO energy of the first body is lower than the LUMO energy of the compounds S1, S2, A1, and A2 in the emission region. In some embodiments, the HOMO energy of the first body is lower than the HOMO energy of the compounds S1, S2, A1 and A2 in the emission region. In some embodiments, the HOMO energy of the first body is higher than the HOMO energy of the compounds S1, S2, A1 and A2 in the emission region. In some embodiments, the HOMO energy of the first body is higher than the HOMO energy of at least one of the compounds S1, S2, A1 and A2 in the emission region.
In some embodiments, the emission region further includes a second body. In some embodiments, the first host forms an exciplex with a second host in the OLED at room temperature.
In some embodiments, the concentration of the first and second bodies in the layer containing the first and second bodies is greater than the concentration of the compounds of S1, S2, A1, and A2 in the layer containing the compounds of S1, S2, A1, and A2. In some embodiments, the concentration of the first and second bodies in the layer containing the first and second bodies is greater than the concentration of the compounds of A1 and A2 in the layer containing the compounds of S1, S2, A1, and A2.
In some embodiments, the concentration of the first and second bodies in the layer containing the first and second bodies is greater than the concentration of the compounds of S1, S2, A1, and A2 in the layer containing the compounds of S1, S2, A1, and A2.
In some embodiments, the S1 energy of the first body is greater than the S1 energy of the compounds of A1 and A2.
In some embodiments, the T1 energy of the first body is greater than the T1 energy of the compounds of S1 and S2.
In some embodiments, at least one of the following conditions holds: (1) The HOMO energy of compound S1 is greater than the HOMO energy of compound A1; (2) The HOMO energy of compound S2 is greater than the HOMO energy of compound A2.
In some embodiments, the first host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, 5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, triazine, borane, silane groups, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole and aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene).
In some embodiments, the sensitizer forms an exciplex with the first host in the OLED at room temperature. In some embodiments, the LUMO energy of the first host is lower than the LUMO energy of the sensitizer compound and the acceptor compound (second compound) in the emission region. In some embodiments, the HOMO energy of the first host is lower than the HOMO energy of the sensitizer compound and the acceptor compound in the emission region. In some embodiments, the HOMO energy of the first host is higher than the HOMO energy of the sensitizer compound and the acceptor compound in the emission region. In some embodiments, the HOMO energy of the first host is higher than the HOMO energy of at least one of the sensitizer and acceptor in the emission region.
In some embodiments, the emission region further includes a second body. In some embodiments, the first host forms an excitation complex with the second host in the OLED at room temperature. In some embodiments, the S 1-T1 energy gap in the excitation complex formed by the first host and the second host is less than 0.4, 0.3, 0.2, or 0.1eV. In some embodiments, the T 1 energy of the excited complex is greater than 2.5, 2.6, 2.7, or 2.8eV. In some embodiments, the concentration of the first and second bodies in the one or more layers containing the first and second bodies is greater than the concentration of the sensitizer compound and the acceptor compound in the one or more layers containing the sensitizer compound and the acceptor compound. In some embodiments, the concentration of the first and second bodies in the one or more layers containing the first and second bodies is greater than the concentration of the acceptor compound in the one or more layers containing the sensitizer compound and the acceptor compound.
In some embodiments, the S 1 energy of the first body is greater than the S 1 energy of the acceptor compound. In some embodiments, the T 1 energy of the first body is greater than the T 1 energy of the sensitizer compound. In some embodiments, the HOMO energy of the sensitizer compound is greater than the HOMO energy of the acceptor compound. In some embodiments, the HOMO level of the second host is shallower than the HOMO level of the acceptor compound. In some embodiments, the HOMO level of the acceptor compound is deeper than at least one selected from the sensitizer compound and the first host.
In some embodiments, the first host and/or the second host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, 5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, triazine, borane, silane groups, nitriles, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, and aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene). In some embodiments, the first body and the second body are both organic compounds.
In some embodiments, at least one of the first body and the second body is a metal complex. In some embodiments, the first body and/or the second body may be selected from the group consisting of:
Wherein:
Each of J 1 to J 6 is independently C or N;
L' is a direct bond or an organic linking group;
Each Y AA、YBB、YCC and Y DD is independently selected from the group consisting of: absence, one bond, direct bond, O, S, se, CRR ', siRR', geRR ', NR, BR, BRR';
each of R A'、RB'、RC'、RD'、RE'、RF 'and R G' independently represents mono-substitution up to maximum substitution or no substitution;
Each R, R ', R A'、RB'、RC'、RD'、RE'、RF ', and R G ' is independently hydrogen or a substituent selected from the group consisting of the universal substituents defined herein; any two substituents may be joined or fused to form a ring;
And, where possible, each unsubstituted aromatic carbon atom is optionally replaced by N to form an aza-substituted ring.
In some embodiments, at least one of J 1 to J 3 is N. In some embodiments, at least two of J 1 to J 3 are N. In some embodiments, all three of J 1 to J 3 are N. In some embodiments, each Y CC and Y DD is preferably O, S and sir', more preferably O or S. In some embodiments, at least one unsubstituted aromatic carbon atom is replaced with N to form an azacyclic ring.
In some embodiments, the HOMO level of compound A1 is deeper than at least one selected from compound S1 and the first host.
In some embodiments, the HOMO level of compound A2 is deeper than at least one selected from compound S2 and the first host.
In some embodiments, the distance between the centers of mass of compound A1 and compound S1 is at least 2nm. In some embodiments, the distance between the centers of mass of compound A1 and compound S1 is at least 1.5nm. In some embodiments, the distance between the centers of mass of compound A1 and compound S1 is at least 1nm. In some embodiments, the distance between the centers of mass of compound A1 and compound S1 is at least 0.75nm.
In some embodiments, the distance between the centers of mass of compound A2 and compound S2 is at least 2nm. In some embodiments, the distance between the centers of mass of compound A2 and compound S2 is at least 1.5nm. In some embodiments, the distance between the centers of mass of compound A2 and compound S2 is at least 1nm. In some embodiments, the distance between the centers of mass of compound A2 and compound S2 is at least 0.75nm.
In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.33. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.30. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.25. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.2. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.15. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.10. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.08. In some embodiments, each of compounds S1, S2, A1, and A2 independently has a VDR value equal to or less than 0.05.
In some embodiments, the VDR value of compound A1 is equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05. In some embodiments, the VDR value of compound S1 is greater than 0.33, 0.4, 0.5, 0.6, or 0.7. In some embodiments, the VDR value of compound A1 is equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05; and the VDR value of the first body is greater than 0.33, 0.4, 0.5, 0.6 or 0.7. In some embodiments, the VDR value of compound A1 is equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05; and at least one of compound S1 and the first body has a VDR value greater than 0.33, 0.4, 0.5, 0.6 or 0.7. In some embodiments, the VDR value of compound A1 is less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05; and the VDR value of the first body is less than 0.33. In some embodiments, the VDR value of the first body is less than 0.33.
In some embodiments, the VDR value of compound A2 is equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05; and at least one of the compound S2 and the first body has a VDR value greater than 0.33, 0.4, 0.5, 0.6 or 0.7.
In some embodiments, the VDR value of compound A1 is equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7. In some embodiments, the VDR value of compound A1 is equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7; and at least one of compound S1 and the first body has a VDR value of less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05. In some embodiments, the VDR value of the first body is equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7. In some embodiments, the VDR value of compound A1 is equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7; and at least one of the compound S1 and the first body has a VDR value equal to or greater than 0.33, 0.4, 0.5, 0.6 or 0.7. In some embodiments, the VDR value of compound A1 is equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7; and the VDR value of the first body is equal to or greater than 0.33, 0.4, 0.5, 0.6 or 0.7. It should be appreciated that in some embodiments, neither S1 nor A1 has a VDR value equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7.
In some embodiments, the VDR value of compound A2 is equal to or greater than 0.33, 0.4, 0.5, 0.6, or 0.7; and at least one of compound S1 and the first body has a VDR value of less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05.
In some embodiments, the emission region further includes a second body. In some embodiments, the second host has a shallower HOMO level than compound A1. In some embodiments, the second host has a shallower HOMO level than compound A2.
In some embodiments, the concentration of compound S1 in the layer containing compound S1 is in the range of 1 to 50 wt%. In some embodiments, the concentration of compound S1 in the layer containing compound S1 is in the range of 1 to 20 wt%. In some embodiments, the concentration of compound S1 in the layer containing compound S1 is in the range of 5 to 20 wt%. In some embodiments, the concentration of compound S1 in the layer containing compound S1 is in the range of 10 to 20 wt%. In some embodiments, the concentration of compound S1 in the layer containing compound S1 is in the range of 8 to 15 wt%. In some embodiments, the concentration of compound S1 in the layer containing compound S1 is in the range of 12 to 15 wt%. In some embodiments, the concentration of compound S2 in the layer containing compound S2 is in the range of 1 to 50 wt%. In some embodiments, the concentration of compound S2 in the layer containing compound S2 is in the range of 5 to 20 wt%. In some embodiments, the concentration of compound S2 in the layer containing compound S2 is in the range of 10 to 20 wt%. In some embodiments, the concentration of compound S2 in the layer containing compound S2 is in the range of 8 to 15 wt%. In some embodiments, the concentration of compound S2 in the layer containing compound S2 is in the range of 12 to 15 wt%.
In some embodiments, the concentration of compound A1 in the layer containing compound A1 is in the range of 0.1 to 10 wt%. In some embodiments, the concentration of compound A1 in the layer containing compound A1 is in the range of 0.1 to 5 wt%. In some embodiments, the concentration of compound A1 in the layer containing compound A1 is in the range of 0.5 to 5 wt%. In some embodiments, the concentration of compound A1 in the layer containing compound A1 is in the range of 0.1 to 3 wt%. In some embodiments, the concentration of compound A1 in the layer containing compound A1 is in the range of 1 to 3 wt%.
In some embodiments, the concentration of compound A2 in the layer containing compound A2 is in the range of 0.1 to 10 wt%. In some embodiments, the concentration of compound A2 in the layer containing compound A2 is in the range of 0.5 to 5 wt%. In some embodiments, the concentration of compound A2 in the layer containing compound A2 is in the range of 1 to 3 wt%.
In some embodiments, compound A1 is a green or yellow emitter in the OLED and compound A2 is a red or NIR emitter in the OLED; wherein compounds A1 and A2 are mixed together in one layer; wherein the concentration of compound A1 is higher than the concentration of compound A2.
In some embodiments, the OLED emits white light at room temperature when a voltage is applied across the device.
In some embodiments, the OLED emits luminescent radiation at room temperature when a voltage is applied across the device; wherein the luminescent radiation comprises a first radiation component provided by compound A1 having emission lambda max1 and a second radiation component provided by compound A2 having emission lambda max2; wherein each of the λ max1 and λ max2 is independently selected from the group consisting of: greater than 340nm to equal to or less than 500nm, greater than 500nm to equal to or less than 600nm, and greater than 600nm to equal to or less than 900nm.
In some embodiments, λ max1 and λ max2 are in the same wavelength range but differ by at least 4nm.
In some embodiments, λ max1 and λ max2 are in different wavelength ranges.
In some embodiments, the FWHM of the first radiation component is 50nm or less. In some embodiments, the FWHM is 40nm or less. In some embodiments, the FWHM is 35nm or less. In some embodiments, the FWHM is 30nm or less. In some embodiments, the FWHM is 25nm or less. In some embodiments, the FWHM is 20nm or less. In some embodiments, the FWHM is 15nm or less. In some embodiments, the FWHM is 10nm or less. In some embodiments, the FWHM is 5nm or less.
In some embodiments, the FWHM of the second radiation component is 50nm or less. In some embodiments, the FWHM is 40nm or less. In some embodiments, the FWHM is 35nm or less. In some embodiments, the FWHM is 30nm or less. In some embodiments, the FWHM is 25nm or less. In some embodiments, the FWHM is 20nm or less. In some embodiments, the FWHM is 15nm or less. In some embodiments, the FWHM is 10nm or less. In some embodiments, the FWHM is 5nm or less.
In some embodiments, 10% of the emission peak of at least one of the first radiation component and the second radiation component starts to be less than 465nm. In some embodiments, 10% of the emission peak of at least one of the first radiation component and the second radiation component starts to be less than 460nm. In some embodiments, 10% of the emission peak of at least one of the first radiation component and the second radiation component starts to be less than 455nm. In some embodiments, 10% of the emission peak of at least one of the first radiation component and the second radiation component starts to be less than 450nm.
In some embodiments, compound S1 is partially or fully deuterated.
In some embodiments, compound S2 is partially or fully deuterated.
In some embodiments, compound A1 is partially or fully deuterated.
In some embodiments, compound A2 is partially or fully deuterated.
In some embodiments, the first body is partially or fully deuterated.
In some embodiments, the second body is partially or fully deuterated.
In some embodiments, one of the first body and the second body is a hole transporting body and the other of the first body and the second body is an electron transporting body.
In some embodiments, the first body is a hole transporting body; and wherein the first body comprises at least one chemical group selected from the group consisting of: amino, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, and 5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole.
In some embodiments, the first body is an electron transport body; and wherein the first body comprises at least one chemical group selected from the group consisting of: pyridine, pyrimidine, pyrazine, pyridazine, triazine, imidazole, aza-triphenylene, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, 5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene, borane, oxa-5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, and oxa- (5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene).
In some embodiments, the emission area further comprises:
compound S3; and
Compound A3;
wherein the compound S3 is a sensitizer that transfers energy to the compound A3;
Wherein the compound A3 is a receptor that acts as an emitter;
wherein the compounds S1, S2, S3 may be the same or different from each other;
wherein the compounds A1, A2 and A3 may be the same or different from each other;
and wherein at least one of the following conditions holds:
(1) At least one of the compounds S1, S2 and S3 is different from the others;
(2) At least one of the compounds A1, A2 and A3 is different from the others.
In another aspect, the present disclosure also provides an Organic Light Emitting Device (OLED) comprising:
An anode;
A first emission region disposed on the anode;
A first Charge Generation Layer (CGL) disposed on the first emission region;
a second transmission region disposed on the first CGL; and
A cathode disposed on the second emission region;
Wherein the first emission area includes:
compound S1; and
A compound A1;
Wherein the second emission region includes:
Compound S2; and
Compound A2;
wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2;
Wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter;
wherein the compound S1 may be the same as or different from the compound S2; and
Wherein the compound A1 may be the same as or different from the compound A2.
In some embodiments, at least one of the following conditions holds:
(1) The compound S1 is different from the compound S2;
(2) The compound A1 is different from the compound A2.
In some embodiments, compound S1 is the same as compound S2.
In some embodiments, compound S1 is different from compound S2.
In some embodiments, compound A1 is the same as compound A2.
In some embodiments, the compound A1 is different from the compound A2.
In some embodiments, the OLED further comprises:
a second CGL disposed over the second emissive region but under the cathode; and
A third emissive region disposed on the second CGL but under the cathode;
Wherein the third emission region includes:
compound S3; and
Compound A3;
wherein the compound S3 is a sensitizer that transfers energy to the compound A3;
Wherein the compound A3 is a receptor that acts as an emitter;
Wherein the compounds S1, S2, S3 may be the same or different from each other; and
Wherein the compounds A1, A2 and A3 may be the same or different from each other.
In some embodiments, at least one of the following conditions holds:
(1) At least one of the compounds S1, S2 and S3 is different from the others;
(2) At least one of the compounds A1, A2 and A3 is different from the others.
In some embodiments, compound A1 is a green emitter in the OLED; and compound A2 is a red or NIR emitter in the OLED.
In some embodiments, compound A1 is a blue emitter in the OLED; and compound A2 is a green, yellow, red or NIR emitter in the OLED.
In some embodiments, compounds A1 and A2 are both blue emitters in the OLED.
In some embodiments, compounds A1 and A2 are both green emitters in the OLED.
In some embodiments, compounds A1 and A2 are both yellow emitters in the OLED.
In some embodiments, compounds A1 and A2 are both red or NIR emitters in the OLED. In some embodiments, when both compounds A1 and A2 are within the same color range, the difference in λ max is less than 20, 15, 10, 8, 6, or 4nm.
In some embodiments, the OLED further comprises a color changing layer or color filter.
In some embodiments, the present disclosure further provides a pixel arrangement of a device comprising:
a first subpixel comprising a first OLED comprising a first emission region;
A second subpixel comprising a second OLED comprising a second emissive region;
Wherein the first emission area includes:
compound S1; and
A compound A1;
Wherein the second emission region includes:
Compound S2; and
Compound A2;
wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2;
Wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter;
wherein the compound S1 may be the same as or different from the compound S2; and
Wherein the compound A1 may be the same as or different from the compound A2.
In some embodiments, at least one of the following conditions holds:
(1) The compound S1 is different from the compound S2;
(2) The compound A1 is different from the compound A2.
In some embodiments, compound S1 is the same as compound S2.
In some embodiments, compound S1 is different from compound S2.
In some embodiments, compound A1 is the same as compound A2.
In some embodiments, the compound A1 is different from the compound A2.
In some embodiments, the pixel arrangement further includes a third sub-pixel including a third OLED including a third emission region.
In some embodiments, the third emission region includes:
compound S3; and
Compound A3;
wherein the compound S3 is a sensitizer that transfers energy to the compound A3;
Wherein the compound A3 is a receptor that acts as an emitter;
Wherein the compounds S1, S2, S3 may be the same or different from each other; and
Wherein the compounds A1, A2 and A3 may be the same or each other; and
And wherein at least one of the following conditions holds:
(1) At least one of the compounds S1, S2 and S3 is different from the others;
(2) At least one of the compounds A1, A2 and A3 is different from the others.
In some embodiments, the pixel arrangement further includes a fourth subpixel including a fourth OLED including a fourth emission area.
In order to reduce the amount of Dexter energy transfer (Dexter ENERGY TRANSFER) between the sensitizer compound and the acceptor compound, a larger distance is preferred between the center of mass of the sensitizer compound and the center of mass of the nearest neighbor acceptor compound in the emission area. Thus, in some embodiments, the distance between the center of mass of the acceptor compound and the center of mass of the sensitizer compound is at least 2, 1.5, 1.0, or 0.75nm.
Preferred receptor/sensitizer VDR combinations (a): in some embodiments, it is preferred that the VDR of the acceptor is below 0.33 compared to an isotropic emitter in order to reduce the coupling of the transition dipole moment of the emission acceptor to the plasma mode in order to achieve a higher outcoupling efficiency. In some cases, when the VDR of the acceptor is less than 0.33, it is preferred that the VDR of the sensitizer is less than 0.33 in order to improve the coupling of the transition dipole moment of the sensitizer and the acceptor, thereby optimizing the forster energy transfer rate. Thus, in some embodiments of the inventive OLED, the acceptor compound in the inventive OLED exhibits a VDR value equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 when the VDR is measured with an emissive thin film test sample having the acceptor compound as the sole emitter; and the sensitizer compound in the OLED of the present invention exhibits a VDR value equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 when the VDR is measured with an emissive thin film test sample having the sensitizer compound as the sole emitter.
Preferred receptor/sensitizer VDR combinations (B): in some embodiments, it is preferred that the VDR of the acceptor be less than 0.33 compared to an isotropic emitter in order to reduce the coupling of the transition dipole moment of the emission acceptor to the plasma mode, thereby achieving a higher outcoupling efficiency. In some cases, when the VDR of the receptor is less than 0.33, it is preferable to minimize the intermolecular interactions between sensitizer and receptor to reduce the degree of Dexter quenching. By altering the molecular geometry of the sensitizer to reduce intermolecular interactions, it may be preferred that the sensitizer have a VDR of greater than 0.33. Thus, in some embodiments of the inventive OLED, the acceptor compound in the inventive OLED exhibits a VDR value equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 when the VDR is measured with an emissive thin film test sample having the acceptor compound as the sole emitter; and the sensitizer compound in the OLED of the present invention exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6 or 0.7 when VDR is measured with an emissive thin film test sample having the sensitizer compound as the sole emitter.
Preferred receptor/sensitizer VDR combinations (C): in some embodiments, it is preferred that the VDR of the acceptor be greater than 0.33 compared to an isotropic emitter in order to increase the coupling of the acceptor's transition dipole moment to the plasma mode, thereby reducing the transient lifetime of the excited state in the emissive layer. In some cases, the increased coupling with the plasma mode may be coordinated with an enhancement layer in the plasma OLED device to increase efficiency and extend operational life. In some cases, when the VDR of the receptor is greater than 0.33, it is preferable to minimize the intermolecular interactions between the sensitizer and the receptor to reduce the extent of the dexwell quenching. By altering the molecular geometry of the sensitizer to reduce intermolecular interactions, it may be preferred that the sensitizer has a VDR of less than 0.33. Thus, in some embodiments of the inventive OLED, the acceptor compound in the inventive OLED exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6, or 0.7 when VDR is measured with an emissive thin film test sample having the acceptor compound as the sole emitter; and the sensitizer compound in the OLED of the present invention exhibits a VDR value equal to or less than 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 when the VDR is measured with an emissive thin film test sample having the sensitizer compound as the sole emitter.
Preferred receptor/sensitizer VDR combinations (D): in some embodiments, it is preferred that the VDR of the acceptor be greater than 0.33 compared to an isotropic emitter in order to increase the coupling of the acceptor's transition dipole moment to the plasma mode, thereby reducing the transient lifetime of the excited state in the emissive layer. In some cases, the increased coupling with the plasma mode may be coordinated with an enhancement layer in the plasma OLED device to increase efficiency and extend operational life. In some cases, when the VDR of the acceptor is less than 0.33, it is preferred that the VDR of the sensitizer is greater than 0.33 in order to improve the coupling of the transition dipole moment of the sensitizer and the acceptor, thereby optimizing the forster energy transfer rate. Thus, in some embodiments of the inventive OLED, the acceptor compound in the inventive OLED exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6, or 0.7 when VDR is measured with an emissive thin film test sample having the acceptor compound as the sole emitter; and the sensitizer compound in the OLED of the present invention exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6 or 0.7 when VDR is measured with an emissive thin film test sample having the sensitizer compound as the sole emitter.
VDR is the overall average fraction of vertically oriented molecular dipoles of the luminescent compound in a thin film sample of the emissive layer, where "vertical" orientation is relative to (i.e., perpendicular to) the plane of the substrate surface on which the thin film sample is formed. A similar concept is the Horizontal Dipole Ratio (HDR), which is the overall average division ratio of the horizontally oriented molecular dipoles of the luminescent compounds in the thin film sample of the emissive layer, where "horizontal" orientation is relative to (i.e., parallel to) the substrate surface plane on which the thin film sample is formed. Vdr+hdr=1 by definition. VDR can be measured by means of an angle dependent, polarization dependent photoluminescence measurement. The VDR of the emissive layer of the thin film test sample can be determined by comparing the measured emission pattern of the optically excited thin film test sample as a function of polarization with a computer modeling pattern. For example, modeled data for p-polarized emission is shown in fig. 3. Modeled p-polarized angular Photoluminescence (PL) of emitters with different VDRs was plotted. The modeled PL peak was observed in p-polarization PL around a 45 degree angle, where the peak PL is larger when the VDR of the emitter is higher.
To measure the VDR value of a thin film test sample, the thin film test sample can be formed using the acceptor compound or sensitizer compound (depending on whether the VDR of the acceptor compound or sensitizer compound is measured) as the sole emitter in the thin film and the reference host compound a as the host. Preferably, the reference host compound a isThin film test samples were formed by thermal evaporation of the emitter compound and the host compound on the substrate. For example, the emitter compound and the host compound may be co-evaporated. In some embodiments, the doping level of the emitter compound in the host may be 0.1wt.% to 50wt.%. In some embodiments, the doping level of the emitter compound in the host may be 3wt.% to 20wt.% for the blue emitter. In some embodiments, the doping level of the emitter compound in the host may be 1wt.% to 15wt.% for the red and green emitters. The thickness of the thermally evaporated thin film test sample may have a thickness of 50 toIs a thickness of (c).
In some embodiments, the OLED of the present disclosure may comprise a sensitizer, an acceptor and one or more hosts in the emissive region, and the preferred acceptor/sensitizer VDR combinations (a) - (D) mentioned above are still applicable. In these embodiments, the VDR value of the acceptor compound may be measured with a thin film test sample formed of one or more hosts and an acceptor, where the acceptor is the only emitter in the thin film test sample. Similarly, the VDR value of a sensitizer compound may be measured with a thin film test sample formed of one or more hosts and a sensitizer, where the sensitizer is the only emitter in the thin film test sample.
In the example used to produce fig. 3, a 30nm thick film of material has a refractive index of 1.75 and the emission is monitored in a semi-infinite medium with a refractive index of 1.75. Each curve was normalized to the photoluminescence intensity 1 (at zero degrees angle perpendicular to the film surface). As the VDR of the emitter varies, the peak around 45 degrees increases substantially. When software is used to fit the VDR of the experimental data, the modeled VDR will change until the differences between the modeled data and the experimental data are minimized.
Since VDR represents the average dipole orientation of the luminescent compounds in the thin film sample, even if other compounds with emission capabilities are present in the emission layer, the VDR measurement does not reflect its VDR if it does not contribute to the light emission. Furthermore, by including a host material that interacts with the luminescent compound, the VDR of the luminescent compound can be modulated. Thus, the luminescent compound in the film sample with host material a will exhibit one VDR measurement and the same luminescent compound in the film sample with host material B will exhibit a different VDR measurement. Furthermore, in some embodiments, excimers or excimer molecules are required that form an emission state between two adjacent molecules. The VDR of these emission states may be different from when the only component in the excitation complex or the excimer is emitted or present in the sample.
In some embodiments, the OLED is a plasmonic OLED. In some embodiments, the OLED is a waveguide OLED.
In some embodiments, the emission region may further include a second body. In some embodiments, the second body includes a portion selected from the group consisting of: bicarbazoles, indolocarbazoles, triazines, pyrimidines, pyridines and boranes. In some embodiments, the HOMO level of the second host is shallower than the HOMO level of the acceptor compound.
In some embodiments, the OLED emits white light at room temperature when a voltage is applied across the device.
In some embodiments, the OLED emits luminescent radiation at room temperature when a voltage is applied across the device; wherein the first radiation emitting component is contributed by an acceptor compound having an emission lambda max1 independently selected from the group consisting of: from greater than 340nm to equal to or less than 500nm, from greater than 500nm to equal to or less than 600nm, and from greater than 600nm to equal to or less than 900nm. In some embodiments, the FWHM of the first radiation component is 50, 40, 35, 30, 25, 20, 15, 10 or 5nm or less. In some embodiments, the first radiation component has an origin of 10% of the emission peak of less than 465, 460, 455, or 450 nm.
In some embodiments, the sensitizer compound is partially or fully deuterated. In some embodiments, the acceptor compound is partially or fully deuterated. In some embodiments, the first body is partially or fully deuterated. In some embodiments, the second body is partially or fully deuterated.
In some embodiments, the sensitizer and/or acceptor each independently comprises at least one substituent having a secondary sphericity greater than or equal to 0.45, 0.55, 0.65, 0.75, or 0.80. Secondary sphericity is a measure of the three dimensions of a bulky group. The secondary sphericity is defined as the ratio between the main moments of inertia (PMI). Specifically, the secondary sphericity is the ratio of three times PMI1 relative to the sum of PMI1, PMI2 and PMI3, where PMI1 is the minimum main moment of inertia, PMI2 is the second minimum main moment of inertia, and PMI3 is the maximum main moment of inertia. The secondary sphericity of the lowest energy conformation of the structure can be calculated after optimizing the ground state using density functional theory. More detailed information can be found in paragraphs [0054] to [0059] of U.S. application Ser. No. 18/062,110 (filed on 6 th 12 th 2022), the contents of which are incorporated herein by reference. In some embodiments, compound S1 and/or compound A1 each independently comprises a van der waals volume greater than 153, 206, 259, 290, orIs a substituent of at least one of the above. In some embodiments, compound S1 and/or compound A1 each independently comprises at least one substituent having a molecular weight greater than 167, 187, 259, 303, or 305 amu.
In some embodiments, one of the first body and the second body is a hole transporting body and the other of the first body and the second body is an electron transporting body. In some embodiments, the first body is a hole transporting body; and wherein the first body comprises at least one chemical group selected from the group consisting of: amino, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, and 5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole. In some embodiments, the first body is an electron transport body; and wherein the first body comprises at least one chemical group selected from the group consisting of: pyridine, pyrimidine, pyrazine, pyridazine, triazine, imidazole, aza-triphenylene, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, 5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, borane-based, nitrile, aza-5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, and aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene). In some embodiments, one of the first and second hosts is a bipolar host comprising a hole transporting portion and an electron transporting portion.
In some embodiments, the OLED further comprises a color shifting layer or color filter.
It will be appreciated that all of the embodiments of the compounds and devices described herein are interchangeable if applicable in different aspects of the overall disclosure.
In some embodiments, each of the sensitizer compounds, acceptor compounds, host compounds described herein may be at least 10% deuterated, at least 20% deuterated, at least 30% deuterated, at least 40% deuterated, at least 50% deuterated, at least 60% deuterated, at least 70% deuterated, at least 80% deuterated, at least 90% deuterated, at least 95% deuterated, at least 99% deuterated, or 100% deuterated. As used herein, deuteration percentage has its ordinary meaning and includes the percentage of possible hydrogen atoms (e.g., hydrogen or deuterium sites) replaced by deuterium atoms.
In yet another aspect, the present disclosure further provides a consumer product comprising an OLED as described herein and comprising a pixel arrangement as described herein.
In some embodiments, the consumer product is selected from the group consisting of: flat panel displays, computer monitors, medical monitors, televisions, billboards, interior or exterior lights and/or lights, head-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, cell phones, tablet computers, tablet phones, personal Digital Assistants (PDAs), wearable devices, notebook computers, digital cameras, video cameras, viewfinders, micro-displays with a diagonal of less than 2 inches, 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising a plurality of displays tiled together, theatre or gym screens, phototherapy devices, and signs.
C. Formulation, chemical structure/assembly and premix co-evaporation source of the present disclosure
In yet another aspect, the present disclosure also provides a formulation comprising different compounds of at least two of the following compounds:
compound S1;
A compound A1;
Compound S2;
Compound A2; and
A first host compound;
Wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature;
Wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature;
wherein the compound S1 may be the same as or different from the compound S2; and
Wherein the compound A1 may be the same as or different from the compound A2; and
And wherein at least one of the following conditions holds:
(1) The compound S1 is different from the compound S2;
(2) The compound A1 is different from the compound A2.
In yet another aspect, the present disclosure also provides a chemical structure selected from the group consisting of: monomers, polymers, macromolecules and supermolecules, wherein the chemical structure comprises at least two of the following components:
compound S1;
A compound A1;
Compound S2;
Compound A2; and
A first host compound;
Wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature;
Wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature;
wherein the compound S1 may be the same as or different from the compound S2; and
Wherein the compound A1 may be the same as or different from the compound A2; and
And wherein at least one of the following conditions holds:
(1) The compound S1 is different from the compound S2;
(2) The compound A1 is different from the compound A2.
In yet another aspect, the present disclosure further provides a premixed co-evaporation source that is a mixture of a first compound and a second compound;
Wherein the co-evaporation source is a co-evaporation source for a vacuum deposition process or an OVJP process;
wherein the first compound and the second compound are selected in different ways from group 1 consisting of:
(1) Compound S1;
(2) A compound A1;
(3) Compound S2;
(4) Compound A2;
(5) A first host compound; and
(6) A second host compound;
Wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature;
Wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature;
wherein the compound S1 may be the same as or different from the compound S2; when compound S1 is the same as compound S2, then the mixture is selected from another element in group 1, and
Wherein the compound A1 may be the same as or different from the compound A2; when compound A1 is the same as compound A2, then the mixture is selected from another element in group 1;
Wherein the first compound has an evaporation temperature T1 of 150 to 350 ℃;
wherein the second compound has an evaporation temperature T2 of 150 to 350 ℃;
wherein the absolute value of T1-T2 is less than 20 ℃;
Wherein the first compound has a concentration C1 in the mixture and a concentration C2 in a film formed as follows: placing the mixture in a vacuum deposition tool at a constant pressure between 1X 10 -6 Torr and 1X 10 -9 Torr on a surface positioned at a predefined distance relative to the vaporized mixture Evaporating at a deposition rate; and
Wherein the absolute value of (C1-C2)/C1 is less than 5%.
In some embodiments, the first compound is selected from the group consisting of: a compound capable of acting as a phosphorescent emitter in an OLED at room temperature, a delayed fluorescence compound acting as a TADF emitter in an OLED at room temperature; wherein the second compound is selected from the group consisting of: a delayed fluorescent compound that acts as a TADF emitter in an OLED at room temperature, a fluorescent compound that acts as an emitter in an OLED at room temperature.
In some embodiments, the mixture further comprises a third compound;
wherein the third compound is different from the first compound and the second compound and is selected from the same group 1;
Wherein the third compound has an evaporation temperature T3 of 150 to 350 ℃ and wherein the absolute value of T1-T3 is less than 20 ℃.
In some embodiments, the first compound has an evaporation temperature T 1 of 200 to 350 ℃ and the second compound has an evaporation temperature T 2 of 200 to 350 ℃.
In some embodiments, (C 1-C2)/C1) has an absolute value of less than 3%.
In some embodiments, the vapor pressure of the first compound at T 1, P 1, is 1atm and the vapor pressure of the second compound at T 2, P 2, is 1atm; and
Wherein the ratio of P 1/P2 is in the range of 0.90:1 to 1.10:1.
In some embodiments, the first compound has a first mass loss rate and the second compound has a second mass loss rate, wherein the ratio between the first mass loss rate and the second mass loss rate is in the range of 0.90:1 to 1.10:1.
In some embodiments, the ratio between the first mass loss rate and the second mass loss rate is in the range of 0.95:1 to 1.05:1.
In some embodiments, the ratio between the first mass loss rate and the second mass loss rate is in the range of 0.97:1 to 1.03:1.
In some embodiments, the first compound and the second compound each have a purity of greater than 99% as determined by high pressure liquid chromatography.
In some embodiments, the composition is in liquid form at a temperature less than the lower of T1 and T2.
D. Method of manufacturing an OLED of the present disclosure
In yet another aspect, the present disclosure also provides a method for manufacturing an organic light emitting device, the method comprising:
providing a substrate having a first electrode disposed thereon;
Depositing a first organic layer on a first electrode by evaporating a pre-mixed co-evaporation source that is a mixture of a first compound and a second compound in a high vacuum deposition tool having a chamber base pressure of 1 x 10 -6 torr to 1 x 10 -9 torr; and
A second electrode is deposited on the first organic layer,
Wherein the first compound and the second compound are selected in different ways from group 1 consisting of:
(1) Compound S1;
(2) A compound A1;
(3) Compound S2;
(4) Compound A2;
(5) A first host compound; and
(6) A second host compound;
Wherein the compound S1 is a sensitizer that transfers energy to the compound A1 in an OLED device at room temperature; and the compound S2 is a sensitizer that transfers energy to the compound A2 in the OLED device at room temperature;
Wherein each of the compounds A1 and A2 is independently an acceptor as an emitter in an OLED device at room temperature;
Wherein the compound S1 may be the same as or different from the compound S2; wherein when said compound S1 is the same as said compound S2 then said mixture is selected from another element in group 1, and
Wherein the compound A1 may be the same as or different from the compound A2; wherein when the compound A1 is the same as the compound A2, then the mixture is selected from another element in group 1;
Wherein the first compound has an evaporation temperature T1 of 150 to 350 ℃;
wherein the second compound has an evaporation temperature T2 of 150 to 350 ℃;
wherein the absolute value of T1-T2 is less than 20 ℃;
Wherein the first compound has a concentration C1 in the mixture and a concentration C2 in a film formed as follows: placing the mixture in a vacuum deposition tool at a constant pressure between 1X 10 -6 Torr and 1X 10 -9 Torr on a surface positioned at a predefined distance relative to the vaporized mixture Evaporating at a deposition rate; and
Wherein the absolute value of (C1-C2)/C1 is less than 5%.
E. Other aspects of the OLED of the present disclosure
In some embodiments, the OLED may further comprise another host, wherein the other host comprises a benzofused thiophene or benzofused furan comprising triphenylene, wherein any substituent in the host is a non-fused substituent :CnH2n+1、OCnH2n+1、OAr1、N(CnH2n+1)2、N(Ar1)(Ar2)、CH=CH-CnH2n+1、C≡CCnH2n+1、Ar1、Ar1-Ar2、CnH2n-Ar1 or an unsubstituted substituent independently selected from the group consisting of, wherein n is an integer from 1 to 10; and wherein Ar 1 and Ar 2 are independently selected from the group consisting of: benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.
In some embodiments, the other host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ2-benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, 5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, triazine, borane, silane groups, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ2-benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, and aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene).
In some embodiments, the other principals may be selected from principal group 1 consisting of:
Wherein:
Each of X 1 to X 24 is independently C or N;
L' is a direct bond or an organic linking group;
each Y A is independently selected from the group consisting of: absence, bond, O, S, se, CRR ', sir', geRR ', NR, BR, BRR';
Each of R A'、RB'、RC'、RD'、RE'、RF' and R G' independently represents mono-to maximum substitution or no substitution;
Each R, R', R A'、RB'、RC'、RD'、RE'、RF', and R G' is independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germanyl, seleno, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borane, and combinations thereof; wherein the organic layer further comprises a host,
Adjacent two of R A'、RB'、RC'、RD'、RE'、RF' and R G' are optionally joined or fused to form a ring.
In some embodiments, the other principal may be selected from a principal group 2 consisting of:
an aza-substituted variant thereof, a fully or partially deuterated variant thereof, and combinations thereof.
In some embodiments, the other host comprises a metal complex.
In yet another aspect, the OLED of the present disclosure may further comprise an emissive region containing a formulation as disclosed in the above compounds section of the present disclosure.
In some embodiments, at least one of the anode, cathode, or new layer disposed over the organic emissive layer serves as the enhancement layer. The enhancement layer includes a plasmonic material exhibiting surface plasmon resonance, the plasmonic material non-radiatively coupled to the emitter material and transferring excited state energy from the emitter material to a non-radiative mode of surface plasmon polaritons. The enhancement layer is disposed no further than a threshold distance from the organic emissive layer, wherein the emitter material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant. In some embodiments, the OLED further comprises an outcoupling layer. In some embodiments, the outcoupling layer is disposed on the enhancement layer on an opposite side of the organic emissive layer. In some embodiments, the outcoupling layer is disposed on the opposite side of the emission layer from the enhancement layer, but is still able to outcouple energy from the surface plasmon mode of the enhancement layer. The outcoupling layer scatters energy from the surface plasmon polaritons. In some embodiments, this energy is scattered into free space as photons. In other embodiments, energy is scattered from surface plasmon modes of the device into other modes, such as, but not limited to, an organic waveguide mode, a substrate mode, or another waveguide mode. If the energy is scattered to the non-free space mode of the OLED, other outcoupling schemes may be incorporated to extract the energy into free space. In some embodiments, one or more intervening layers may be disposed between the enhancement layer and the outcoupling layer. Examples of intervening layers may be dielectric materials, including organic, inorganic, perovskite, oxides, and may include stacks and/or mixtures of these materials.
The enhancement layer alters the effective properties of the medium in which the emitter material resides, causing any or all of the following: reduced emissivity, altered emission linearity, altered emission intensity with angle, altered emitter material stability, altered OLED efficiency, and reduced OLED device roll-off efficiency. Placing the enhancement layer on the cathode side, the anode side, or both sides creates an OLED device that takes advantage of any of the effects described above. In addition to the specific functional layers mentioned herein and illustrated in the various OLED examples shown in the figures, an OLED according to the present disclosure may also include any other functional layers common in OLEDs.
The enhancement layer may comprise a plasmonic material, an optically active super-structured material or a hyperbolic super-structured material. As used herein, a plasmonic material is a material in which the real part of the dielectric constant crosses zero in the visible or ultraviolet region of the electromagnetic spectrum. In some embodiments, the plasmonic material comprises at least one metal. In such embodiments, the metal may include at least one of the following: ag. Al, au, ir, pt, ni, cu, W, ta, fe, cr, mg, ga, rh, ti, ru, pd, in, bi, ca, alloys or mixtures of these materials, and stacks of these materials. Generally, a metamaterial is a medium composed of different materials, wherein the overall effect of the medium is different from the sum of its material portions. In particular, we define an optically active super-structured material as a material having both negative permittivity and negative permeability. On the other hand, hyperbolic metamaterials are anisotropic media in which the permittivity or permeability has different signs for different spatial directions. Optically active and hyperbolic metamaterials are very different from many other photonic structures, such as distributed Bragg reflectors (Distributed Bragg Reflector, "DBRs"), because the medium should exhibit uniformity in the direction of propagation over the length scale of the wavelength of light. Using terms that will be understood by those skilled in the art: the dielectric constant of a metamaterial in the propagation direction can be described by an effective dielectric approximation. Plasmonic and super-structured materials provide a method for controlling light propagation that can enhance OLED performance in a variety of ways.
In some embodiments, the enhancement layer is provided as a planar layer. In other embodiments, the enhancement layer has wavelength-sized features that are periodically, quasi-periodically, or randomly arranged, or sub-wavelength-sized features that are periodically, quasi-periodically, or randomly arranged. In some embodiments, the wavelength-sized features and the sub-wavelength-sized features have sharp edges.
In some embodiments, the outcoupling layer has wavelength-sized features that are periodically, quasi-periodically, or randomly arranged, or sub-wavelength-sized features that are periodically, quasi-periodically, or randomly arranged. In some embodiments, the outcoupling layer may be composed of a plurality of nanoparticles, and in other embodiments, the outcoupling layer is composed of a plurality of nanoparticles disposed over the material. In these embodiments, the outcoupling may be adjusted by at least one of the following means: changing the size of the plurality of nanoparticles, changing the shape of the plurality of nanoparticles, changing the material of the plurality of nanoparticles, adjusting the thickness of the material, changing the refractive index of the material or an additional layer disposed on the plurality of nanoparticles, changing the thickness of the reinforcing layer, and/or changing the material of the reinforcing layer. The plurality of nanoparticles of the device may be formed from at least one of: a metal, a dielectric material, a semiconductor material, a metal alloy, a mixture of dielectric materials, a stack or layering of one or more materials and/or a core of one type of material and a shell coated with another type of material. In some embodiments, the outcoupling layer is composed of at least metal nanoparticles, wherein the metal is selected from the group consisting of: ag. Al, au, ir, pt, ni, cu, W, ta, fe, cr, mg, ga, rh, ti, ru, pd, in, bi, ca, alloys or mixtures of these materials, and stacks of these materials. The plurality of nanoparticles may have additional layers disposed over them. In some embodiments, the polarization of the emission may be adjusted using an outcoupling layer. Changing the size and periodicity of the outcoupling layer may select the type of polarization that preferentially outcouples to air. In some embodiments, the outcoupling layer also serves as an electrode of the device.
In yet another aspect, the present disclosure also provides a consumer product comprising an Organic Light Emitting Device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer may comprise a compound as disclosed in the above compound section of the disclosure.
In some embodiments, the consumer product comprises an OLED having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer may comprise a formulation as described herein.
In some embodiments, the consumer product may be one of the following products: flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, cellular telephones, tablet computers, tablet handsets, personal Digital Assistants (PDAs), wearable devices, laptop computers, digital cameras, video cameras, viewfinders, micro-displays with a diagonal of less than 2 inches, 3-D displays, virtual or augmented reality displays, vehicles, video walls comprising a plurality of displays tiled together, theatre or gym screens, phototherapy devices, and billboards.
In general, an OLED includes at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer. The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and a hole are localized on the same molecule, an "exciton" is formed, which is a localized electron-hole pair having an excited energy state. Light is emitted when the exciton relaxes through a light emission mechanism. In some cases, excitons may be localized on an excimer (excimer) or an exciplex. Non-radiative mechanisms (such as thermal relaxation) may also occur, but are generally considered undesirable.
Several OLED materials and configurations are described in U.S. patent nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.
Initial OLEDs used emissive molecules that emitted light ("fluorescence") from a singlet state, as disclosed, for example, in U.S. patent No. 4,769,292, which is incorporated by reference in its entirety. Fluorescence emission typically occurs in time frames less than 10 nanoseconds.
Recently, OLEDs have been demonstrated that have emissive materials that emit light from a triplet state ("phosphorescence"). Baldo et al, "efficient phosphorescent emission from organic electroluminescent devices (HIGHLY EFFICIENT Phosphorescent Emission from Organic Electroluminescent Devices)", nature, volume 395, 151-154,1998 ("Baldo-I"); and Barduo et al, "Very high efficiency green organic light emitting device based on electrophosphorescence (Very high-EFFICIENCY GREEN organic light-EMITTING DEVICES based on electrophosphorescence)", applied physical fast report (appl. Phys. Lett.), vol.75, stages 3,4-6 (1999) ("Barduo-II"), incorporated by reference in its entirety. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704, columns 5-6, which is incorporated by reference.
Fig. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. The device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a blocking layer 170. Cathode 160 is a composite cathode having a first conductive layer 162 and a second conductive layer 164. The device 100 may be fabricated by depositing the layers in sequence. The nature and function of these various layers and example materials are described in more detail in U.S. Pat. No. 7,279,704 at columns 6-10, which is incorporated by reference.
Further examples of each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. patent No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F 4 -TCNQ at a molar ratio of 50:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of luminescent and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li in a molar ratio of 1:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of cathodes are disclosed in U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, that include composite cathodes having a thin layer of metal (e.g., mg: ag) containing an overlying transparent, electrically conductive, sputter-deposited ITO layer. The theory and use of barrier layers is described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. Examples of implanted layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers can be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
Fig. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. The device 200 may be fabricated by depositing the layers in sequence. Because the most common OLED configuration has a cathode disposed above an anode, and the device 200 has a cathode 215 disposed below an anode 230, the device 200 may be referred to as an "inverted" OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. Fig. 2 provides one example of how some layers may be omitted from the structure of the apparatus 100.
The simple layered structure illustrated in fig. 1 and 2 is provided by way of non-limiting example, and it should be understood that embodiments of the present disclosure may be used in conjunction with a variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be obtained by combining the various layers described in different ways, or the layers may be omitted entirely based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe the various layers as comprising a single material, it should be understood that combinations of materials may be used, such as mixtures of host and dopant, or more generally, mixtures. Further, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to fig. 1 and 2.
Structures and materials not specifically described, such as OLEDs (PLEDs) comprising polymeric materials, such as disclosed in frank (Friend) et al, U.S. patent No. 5,247,190, which is incorporated by reference in its entirety, may also be used. By way of another example, an OLED with a single organic layer may be used. The OLEDs can be stacked, for example, as described in U.S. patent No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in fig. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Furster et al, and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Boolean et al, which are incorporated by reference in their entirety.
Any of the layers of the various embodiments may be deposited by any suitable method unless otherwise specified. Preferred methods for the organic layer include thermal evaporation, ink jet (e.g., as described in U.S. Pat. nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entirety), organic vapor deposition (OVPD) (e.g., as described in U.S. Pat. No. 6,337,102 to Forrest et al, which is incorporated by reference in its entirety), and deposition by organic vapor jet printing (OVJP, also known as Organic Vapor Jet Deposition (OVJD)), which is described in, e.g., U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin-coating and other solution-based processes. The solution-based process is preferably carried out under nitrogen or an inert atmosphere. For other layers, the preferred method includes thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding (e.g., as described in U.S. Pat. nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entirety), and patterning associated with some deposition methods such as inkjet and Organic Vapor Jet Printing (OVJP). Other methods may also be used. The material to be deposited may be modified to suit the particular deposition method. For example, substituents such as alkyl and aryl groups that are branched or unbranched and preferably contain at least 3 carbons can be used in small molecules to enhance their ability to withstand solution processing. Substituents having 20 carbons or more may be used, and 3 to 20 carbons are a preferred range. A material with an asymmetric structure may have better solution processibility than a material with a symmetric structure because an asymmetric material may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated according to embodiments of the present disclosure may further optionally include a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damage when exposed to harmful substances in an environment including moisture, vapor, and/or gases, etc. The barrier layer may be deposited on the substrate, electrode, under or beside the substrate, electrode, or on any other portion of the device, including the edge. The barrier layer may comprise a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include a composition having a single phase as well as a composition having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate inorganic compounds or organic compounds or both. Preferred barrier layers comprise a mixture of polymeric and non-polymeric materials, as described in U.S. patent No. 7,968,146, PCT patent application No. PCT/US2007/023098, and PCT/US2009/042829, which are incorporated herein by reference in their entirety. To be considered a "mixture", the aforementioned polymeric and non-polymeric materials that make up the barrier layer should be deposited under the same reaction conditions and/or simultaneously. The weight ratio of polymeric material to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be produced from the same precursor material. In one example, the mixture of polymeric and non-polymeric materials consists essentially of polymeric silicon and inorganic silicon.
Devices manufactured in accordance with embodiments of the present disclosure may be incorporated into a wide variety of electronic component modules (or units), which may be incorporated into a wide variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices (e.g., discrete light source devices or lighting panels), etc., that may be utilized by end user product manufacturers. The electronics assembly module may optionally include drive electronics and/or a power source. Devices manufactured in accordance with embodiments of the present disclosure may be incorporated into a wide variety of consumer products having one or more electronic component modules (or units) incorporated therein. Disclosed is a consumer product comprising an OLED comprising a compound of the present disclosure in an organic layer in the OLED. The consumer product should include any kind of product that contains one or more light sources and/or one or more of some type of visual display. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, cellular telephones, tablet computers, tablet phones, personal Digital Assistants (PDAs), wearable devices, laptop computers, digital cameras, video cameras, viewfinders, micro-displays (displays with a diagonal of less than 2 inches), 3-D displays, virtual or augmented reality displays, vehicles, video walls including a plurality of tiled displays, theatre or gym screens, phototherapy devices, and signs. Various control mechanisms may be used to control devices manufactured in accordance with the present disclosure, including passive matrices and active matrices. Many of the devices are intended to be used in a temperature range that is comfortable for humans, such as 18 ℃ to 30 ℃, and more preferably at room temperature (20-25 ℃), but can be used outside this temperature range (e.g., -40 ℃ to +80 ℃).
Further details regarding OLEDs and the definitions described above can be found in U.S. patent No. 7,279,704, which is incorporated herein by reference in its entirety.
The materials and structures described herein may be applied in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices such as organic transistors may employ the materials and structures.
In some embodiments, the OLED has one or more features selected from the group consisting of: flexible, crimpable, collapsible, stretchable and bendable. In some embodiments, the OLED is transparent or translucent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.
In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED includes an RGB pixel arrangement or a white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a handheld device, or a wearable device. In some embodiments, the OLED is a display panel having a diagonal of less than 10 inches or an area of less than 50 square inches. In some embodiments, the OLED is a display panel having a diagonal of at least 10 inches or an area of at least 50 square inches. In some embodiments, the OLED is an illumination panel.
In some embodiments, the compound may be an emissive dopant. In some embodiments, the compounds may produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as delayed fluorescence of type E, see, e.g., U.S. application No. 15/700,352, which is incorporated herein by reference in its entirety), triplet-triplet annihilation, or combinations of these processes. In some embodiments, the emissive dopant may be a racemic mixture, or may be enriched in one enantiomer. In some embodiments, the compounds may be homoleptic (identical for each ligand). In some embodiments, the compounds may be compounded (at least one ligand is different from the others). In some embodiments, when there is more than one ligand coordinated to the metal, the ligands may all be the same. In some other embodiments, at least one ligand is different from the other ligands. In some embodiments, each ligand may be different from each other. This is also true in embodiments where the ligand coordinated to the metal may be linked to other ligands coordinated to the metal to form a tridentate, tetradentate, pentadentate or hexadentate ligand. Thus, where the coordinating ligands are linked together, in some embodiments all of the ligands may be the same, and in some other embodiments at least one of the linking ligands may be different from the other ligand(s).
In some embodiments, the compounds may be used as a phosphor-photosensitizing agent in an OLED, where one or more layers in the OLED contain receptors in the form of one or more fluorescent and/or delayed fluorescent emitters. In some embodiments, the compound may be used as a component of an exciplex to be used as a sensitizer. As a phosphorus photosensitizer, the compound must be able to transfer energy to the acceptor and the acceptor will emit energy or further transfer energy to the final emitter. The receptor concentration may be in the range of 0.001% to 100%. The acceptor may be in the same layer as the phosphorus photosensitizer or in one or more different layers. In some embodiments, the receptor is a TADF emitter. In some embodiments, the acceptor is a fluorescent emitter. In some embodiments, the emission may be produced by any or all of the sensitizer, acceptor, and final emitter.
According to another aspect, a formulation comprising a compound described herein is also disclosed.
The OLEDs disclosed herein can be incorporated into one or more of consumer products, electronics assembly modules, and lighting panels. The organic layer may be an emissive layer, and the compound may be an emissive dopant in some embodiments, and the compound may be a non-emissive dopant in other embodiments.
In yet another aspect of the invention, a formulation comprising the novel compounds disclosed herein is described. The formulation may comprise one or more components disclosed herein selected from the group consisting of: a solvent, a host, a hole injection material, a hole transport material, an electron blocking material, a hole blocking material, and an electron transport material.
The present disclosure encompasses any chemical structure comprising the novel compounds of the present disclosure or monovalent or multivalent variants thereof. In other words, the compounds of the invention or monovalent or multivalent variants thereof may be part of a larger chemical structure. Such chemical structures may be selected from the group consisting of: monomers, polymers, macromolecules, and supramolecules (supramolecule) (also referred to as supramolecules (supermolecule)). As used herein, "monovalent variant of a compound" refers to the same moiety as the compound but with one hydrogen removed and replaced with a bond to the rest of the chemical structure. As used herein, "multivalent variant of a compound" refers to a moiety that is identical to the compound but where more than one hydrogen has been removed and replaced with one or more bonds to the rest of the chemical structure. In the case of supramolecules, the compounds of the present invention may also be incorporated into supramolecular complexes without covalent bonds.
F. combinations of compounds of the present disclosure with other materials
Materials described herein as suitable for use in particular layers in an organic light emitting device may be used in combination with a variety of other materials present in the device. For example, the emissive dopants disclosed herein can be used in combination with a wide variety of hosts, transport layers, barrier layers, implant layers, electrodes, and other layers that may be present. The materials described or mentioned below are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one of ordinary skill in the art may readily review the literature to identify other materials that may be used in combination.
A) Conductive dopants:
The charge transport layer may be doped with a conductive dopant to substantially change its charge carrier density, which in turn will change its conductivity. Conductivity is increased by the generation of charge carriers in the host material and, depending on the type of dopant, a change in the fermi level (FERMI LEVEL) of the semiconductor can also be achieved. The hole transport layer may be doped with a p-type conductivity dopant, and an n-type conductivity dopant is used in the electron transport layer.
Non-limiting examples of conductive dopants that can be used in OLEDs in combination with the materials disclosed herein are exemplified below :EP01617493、EP01968131、EP2020694、EP2684932、US20050139810、US20070160905、US20090167167、US2010288362、WO06081780、WO2009003455、WO2009008277、WO2009011327、WO2014009310、US2007252140、US2015060804、US20150123047 and US2012146012 along with references disclosing those materials.
b)HIL/HTL:
The hole injection/transport material used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is generally used as a hole injection/transport material. Examples of materials include (but are not limited to): phthalocyanines or porphyrin derivatives; aromatic amine derivatives; indolocarbazole derivatives; a fluorocarbon-containing polymer; a polymer having a conductive dopant; conductive polymers such as PEDOT/PSS; self-assembled monomers derived from compounds such as phosphonic acids and silane derivatives; metal oxide derivatives such as MoO x; p-type semiconducting organic compounds such as 1,4,5,8,9, 12-hexaazatriphenylene hexacarbonitrile; a metal complex; a crosslinkable compound.
Examples of aromatic amine derivatives for the HIL or HTL include, but are not limited to, the following general structures:
Each of Ar 1 to Ar 9 is selected from: a group consisting of, for example, the following aromatic hydrocarbon cyclic compounds: benzene, biphenyl, triphenylene, naphthalene, anthracene, benzene, phenanthrene, fluorene, pyrene, and the like, Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuranpyridine, furandipyridine, benzothiophenopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from an aromatic hydrocarbon ring group and an aromatic heterocyclic group and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit, and an aliphatic ring group. Each Ar may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, ar 1 to Ar 9 are independently selected from the group consisting of:
wherein k is an integer from 1 to 20; x 101 to X 108 are C (including CH) or N; z 101 is NAr 1, O or S; ar 1 has the same groups as defined above.
Examples of metal complexes used in the HIL or HTL include, but are not limited to, the following general formula:
Wherein Met is a metal that may have an atomic weight greater than 40; (Y 101-Y102) is a bidentate ligand, Y 101 and Y 102 are independently selected from C, N, O, P and S; l 101 is a secondary ligand; k' is an integer value of 1 to the maximum number of ligands that can be attached to the metal; and k' +k "is the maximum number of ligands that can be attached to the metal.
In one aspect, (Y 101-Y102) is a 2-phenylpyridine derivative. In another aspect, (Y 101-Y102) is a carbene ligand. In another aspect, met is selected from Ir, pt, os, and Zn. In another aspect, the metal complex has a minimum oxidation potential in solution of less than about 0.6V compared to Fc +/Fc coupling.
Non-limiting examples of HIL and HTL materials that can be used in an OLED in combination with the materials disclosed herein are exemplified below along with references disclosing those materials :CN102702075、DE102012005215、EP01624500、EP01698613、EP01806334、EP01930964、EP01972613、EP01997799、EP02011790、EP02055700、EP02055701、EP1725079、EP2085382、EP2660300、EP650955、JP07-073529、JP2005112765、JP2007091719、JP2008021687、JP2014-009196、KR20110088898、KR20130077473、TW201139402、US06517957、US20020158242、US20030162053、US20050123751、US20060182993、US20060240279、US20070145888、US20070181874、US20070278938、US20080014464、US20080091025、US20080106190、US20080124572、US20080145707、US20080220265、US20080233434、US20080303417、US2008107919、US20090115320、US20090167161、US2009066235、US2011007385、US20110163302、US2011240968、US2011278551、US2012205642、US2013241401、US20140117329、US2014183517、US5061569、US5639914、WO05075451、WO07125714、WO08023550、WO08023759、WO2009145016、WO2010061824、WO2011075644、WO2012177006、WO2013018530、WO2013039073、WO2013087142、WO2013118812、WO2013120577、WO2013157367、WO2013175747、WO2014002873、WO2014015935、WO2014015937、WO2014030872、WO2014030921、WO2014034791、WO2014104514、WO2014157018.
c)EBL:
An Electron Blocking Layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime than a similar device lacking such a barrier layer. Furthermore, a blocking layer may be used to limit the emission to a desired area of the OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in the EBL contains the same molecule or the same functional group as used in one of the hosts described below.
D) A main body:
The light-emitting layer of the organic EL device of the present disclosure preferably contains at least a metal complex as a light-emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complex or organic compound may be used as long as the triplet energy of the host is greater than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria are met.
Examples of metal complexes used as hosts preferably have the general formula:
Wherein Met is a metal; (Y 103-Y104) is a bidentate ligand, Y 103 and Y 104 are independently selected from C, N, O, P and S; l 101 is another ligand; k' is an integer value of 1 to the maximum number of ligands that can be attached to the metal; and k' +k "is the maximum number of ligands that can be attached to the metal.
In one aspect, the metal complex is:
wherein (O-N) is a bidentate ligand having a metal coordinated to the O and N atoms.
In another aspect, met is selected from Ir and Pt. In another aspect, (Y 103-Y104) is a carbene ligand.
In one aspect, the host compound contains at least one selected from the group consisting of: a group consisting of, for example, the following aromatic hydrocarbon cyclic compounds: benzene, biphenyl, triphenylene, tetramethylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene,Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuranpyridine, furandipyridine, benzothiophenopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from an aromatic hydrocarbon ring group and an aromatic heterocyclic group and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit, and an aliphatic ring group. Each option in each group may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the host compound contains in the molecule at least one of the following groups:
Wherein R 101 is selected from the group consisting of: hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has a similar definition as Ar mentioned above. k is an integer from 0 to 20 or from 1 to 20. X 101 to X 108 are independently selected from C (including CH) or N. Z 101 and Z 102 are independently selected from NR 101, O or S.
Non-limiting examples of host materials that can be used in OLEDs in combination with the materials disclosed herein are exemplified below along with references disclosing those materials :EP2034538、EP2034538A、EP2757608、JP2007254297、KR20100079458、KR20120088644、KR20120129733、KR20130115564、TW201329200、US20030175553、US20050238919、US20060280965、US20090017330、US20090030202、US20090167162、US20090302743、US20090309488、US20100012931、US20100084966、US20100187984、US2010187984、US2012075273、US2012126221、US2013009543、US2013105787、US2013175519、US2014001446、US20140183503、US20140225088、US2014034914、US7154114、WO2001039234、WO2004093207、WO2005014551、WO2005089025、WO2006072002、WO2006114966、WO2007063754、WO2008056746、WO2009003898、WO2009021126、WO2009063833、WO2009066778、WO2009066779、WO2009086028、WO2010056066、WO2010107244、WO2011081423、WO2011081431、WO2011086863、WO2012128298、WO2012133644、WO2012133649、WO2013024872、WO2013035275、WO2013081315、WO2013191404、WO2014142472,US20170263869、US20160163995、US9466803,
E) Other emitters:
One or more other emitter dopants may be used in combination with the compounds of the present invention. Examples of other emitter dopants are not particularly limited, and any compound may be used as long as the compound is generally used as an emitter material. Examples of suitable emitter materials include, but are not limited to, compounds that can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.
Non-limiting examples of emitter materials that can be used in OLEDs in combination with the materials disclosed herein are exemplified below along with references disclosing those materials :CN103694277、CN1696137、EB01238981、EP01239526、EP01961743、EP1239526、EP1244155、EP1642951、EP1647554、EP1841834、EP1841834B、EP2062907、EP2730583、JP2012074444、JP2013110263、JP4478555、KR1020090133652、KR20120032054、KR20130043460、TW201332980、US06699599、US06916554、US20010019782、US20020034656、US20030068526、US20030072964、US20030138657、US20050123788、US20050244673、US2005123791、US2005260449、US20060008670、US20060065890、US20060127696、US20060134459、US20060134462、US20060202194、US20060251923、US20070034863、US20070087321、US20070103060、US20070111026、US20070190359、US20070231600、US2007034863、US2007104979、US2007104980、US2007138437、US2007224450、US2007278936、US20080020237、US20080233410、US20080261076、US20080297033、US200805851、US2008161567、US2008210930、US20090039776、US20090108737、US20090115322、US20090179555、US2009085476、US2009104472、US20100090591、US20100148663、US20100244004、US20100295032、US2010102716、US2010105902、US2010244004、US2010270916、US20110057559、US20110108822、US20110204333、US2011215710、US2011227049、US2011285275、US2012292601、US20130146848、US2013033172、US2013165653、US2013181190、US2013334521、US20140246656、US2014103305、US6303238、US6413656、US6653654、US6670645、US6687266、US6835469、US6921915、US7279704、US7332232、US7378162、US7534505、US7675228、US7728137、US7740957、US7759489、US7951947、US8067099、US8592586、US8871361、WO06081973、WO06121811、WO07018067、WO07108362、WO07115970、WO07115981、WO08035571、WO2002015645、WO2003040257、WO2005019373、WO2006056418、WO2008054584、WO2008078800、WO2008096609、WO2008101842、WO2009000673、WO2009050281、WO2009100991、WO2010028151、WO2010054731、WO2010086089、WO2010118029、WO2011044988、WO2011051404、WO2011107491、WO2012020327、WO2012163471、WO2013094620、WO2013107487、WO2013174471、WO2014007565、WO2014008982、WO2014023377、WO2014024131、WO2014031977、WO2014038456、WO2014112450.
f)HBL:
A Hole Blocking Layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime than a similar device lacking the barrier layer. Furthermore, a blocking layer may be used to limit the emission to a desired area of the OLED. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.
In one aspect, the compound used in the HBL contains the same molecules or the same functional groups as used in the host described above.
In another aspect, the compound used in the HBL contains in the molecule at least one of the following groups:
Wherein k is an integer from 1 to 20; l 101 is another ligand and k' is an integer from 1 to 3.
g)ETL:
An Electron Transport Layer (ETL) may include a material capable of transporting electrons. The electron transport layer may be intrinsic (undoped) or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complex or organic compound may be used as long as it is generally used to transport electrons.
In one aspect, the compounds used in ETL contain in the molecule at least one of the following groups:
Wherein R 101 is selected from the group consisting of: hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, when aryl or heteroaryl, have similar definitions as for Ar described above. Ar 1 to Ar 3 have similar definitions to Ar mentioned above. k is an integer of 1 to 20. X 101 to X 108 are selected from C (including CH) or N.
In another aspect, the metal complex used in ETL contains (but is not limited to) the following formula:
wherein (O-N) or (N-N) is a bidentate ligand having a metal coordinated to atom O, N or N, N; l 101 is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal.
Non-limiting examples of ETL materials that can be used in OLEDs in combination with the materials disclosed herein are exemplified below along with references disclosing those materials :CN103508940、EP01602648、EP01734038、EP01956007、JP2004-022334、JP2005149918、JP2005-268199、KR0117693、KR20130108183、US20040036077、US20070104977、US2007018155、US20090101870、US20090115316、US20090140637、US20090179554、US2009218940、US2010108990、US2011156017、US2011210320、US2012193612、US2012214993、US2014014925、US2014014927、US20140284580、US6656612、US8415031、WO2003060956、WO2007111263、WO2009148269、WO2010067894、WO2010072300、WO2011074770、WO2011105373、WO2013079217、WO2013145667、WO2013180376、WO2014104499、WO2014104535,
H) Charge Generation Layer (CGL)
In tandem or stacked OLEDs, CGL plays a fundamental role in performance, consisting of n-doped and p-doped layers for injecting electrons and holes, respectively. Electrons and holes are supplied by the CGL and the electrode. Electrons and holes consumed in the CGL are refilled with electrons and holes injected from the cathode and anode, respectively; subsequently, the bipolar current gradually reaches a steady state. Typical CGL materials include n and p conductivity dopants used in the transport layer.
In any of the above mentioned compounds used in each layer of the OLED device, the hydrogen atoms may be partially or fully deuterated. The minimum amount of deuterated hydrogen in the compound is selected from the group consisting of: 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99% and 100%. Thus, any of the specifically listed substituents, such as (but not limited to) methyl, phenyl, pyridyl, and the like, can be in their non-deuterated, partially deuterated, and fully deuterated forms. Similarly, substituent classes (e.g., without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc.) can also be in their non-deuterated, partially deuterated, and fully deuterated forms.
It should be understood that the various embodiments described herein are for purposes of example only and are not intended to limit the scope of the present invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the invention. The invention as claimed may therefore include variations of the specific examples and preferred embodiments described herein, as will be apparent to those skilled in the art. It should be understood that the various theories as to why the present invention works are not intended to be limiting.
It should also be understood that all of the embodiments of the compounds and devices described herein are interchangeable if applicable in different aspects of the disclosure as a whole.
D. Experimental section.
The following material sets were used to fabricate OLED devices.
The OLED was grown on a glass substrate pre-coated with an Indium Tin Oxide (ITO) layer having a sheet resistance of 15- Ω/sq. The substrate was degreased with a solvent before any organic layers were deposited or coated, and then treated with an oxygen plasma at 100 millitorr, 50W for 1.5 minutes and with UV ozone for 5 minutes. The device was manufactured by thermal evaporation in a high vacuum (< 10 -6 torr). The anode electrode beingIndium Tin Oxide (ITO). Immediately after manufacture, all devices were enclosed with epoxy-sealed glass caps in a nitrogen glove box (< 1ppm H 2 O and O 2), and moisture absorbent was incorporated into the package interior. The doping percentages are in volume percent.
The four devices were grown with an organic layer consisting of, in order from the ITO surface: Compound 1 (HIL),/> Compound 2 (HTL),Compound 3 (EBL), EML,Compound 4 (BL),Compound 5 (ETL),/>, doped with 35% Compound 6Compound 5 (EIL), followed byAl (cathode).
The composition of EML is shown in Table 1
Table 1: EML composition
EML composition | |
Comparison device 1 | Compound 3:35% compound 4:12% phosphor 1:1% receptor 1 |
Example 1 | Compound 3:35% compound 4:12% phosphor 1:3% phosphor 2:1% receptor 1 |
Example 2 | Compound 3:35% compound 4:12% phosphor 1:1% acceptor 2 |
Example 3 | Compound 3:35% compound 4:12% phosphor 1:3% phosphor 2:1% acceptor 1:1% acceptor 2 |
Emission characteristics, voltage and EQE are reported in table 2, where voltage and EQE are taken at 10mA/cm 2 and reported relative to the value of comparative device 1.
Table 2: device data
Device and method for controlling the same | CIE | λmax(nm) | Relative voltage (V) | Relative EQE |
Comparison device 1 | (0.141,0.124) | 458 | 1.00 | 1.00 |
Example 1 | (0.142,0.128) | 458 | 0.96 | 0.98 |
Example 2 | (0.125,0.113) | 470 | 1.03 | 1.45 |
Example 3 | (0.125,0.116) | 470 | 1.00 | 1.47 |
The above data shows that by using two sensitizers under the same other conditions (example 1 versus comparative device 1, and example 3 versus example 2) a 3-4% voltage reduction can be produced relative to the same device without the second sensitizer. Meanwhile, by using two receptors under the same other conditions (example 2 vs. comparative device 1 and example 3 vs. example 1), it is possible to have an EQE 45% to 49% higher than the same device without the second receptor. In addition, the introduction of the second acceptor produces a more saturated color coordinate despite the red-shifted emission maximum. Without being bound by any theory, this improvement may be attributed to better charge transport, charge recombination, and/or exciton collection by the additional sensitizer, as well as an increase in energy transfer efficiency upon addition of the additional fluorescent acceptor. These improvements are beyond any value attributable to experimental error and are significant. The present invention thus provides a new way to improve the performance of a sensitising device by using two sensitizers or two receptors or both.
Claims (15)
1. An organic light emitting device OLED comprising:
An anode;
A cathode; and
An emissive region disposed between the anode and the cathode;
wherein the emission area comprises:
compound S1;
A compound A1;
Compound S2; and
Compound A2;
wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2;
Wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter;
wherein the compound S1 may be the same as or different from the compound S2;
Wherein the compound A1 may be the same as or different from the compound A2; and
Wherein at least one of the following conditions holds:
(1) The compound S1 is different from the compound S2; or (b)
(2) The compound A1 is different from the compound A2.
2. The OLED of claim 1, wherein each of the compounds S1 and S2 is independently capable of acting as a phosphorescent emitter, TADF emitter, or a dual state emitter in an OLED at room temperature.
3. The OLED of claim 1, wherein the A1 and A2 compounds each have a S 1 energy lower than the S 1 energy of the compounds S1 and S2; and/or wherein the S 1-T1 energy gap of the compound S1 is less than 300meV; and/or wherein the S 1-T1 energy gap of the compound S2 is less than 300meV; and/or wherein the S 1-T1 energy gap of compound A1 is less than 300meV; and/or wherein the S 1-T1 energy gap of compound A2 is less than 300meV.
4. The OLED of claim 1, wherein the compound S1 has an emission maximum of lambda max1 in a single-color OLED with a host at room temperature; wherein by replacing the compound S1 with the compound A1, the compound A1 has an emission maximum of lambda max2 in the monochrome OLED; wherein Δλ=λ max1-λmax2; and wherein Δλ is equal to or greater than a value selected from the group consisting of: 20. 30, 40, 60, 80, 100nm; and/or said compound S2 has an emission maximum of lambda max1 in a single-colour OLED with a host at room temperature; wherein by replacing the compound S2 with the compound A2, the compound A2 has an emission maximum of lambda max3 in the monochrome OLED; wherein Δλ=λ max1-λmax3; and wherein Δλ is equal to or greater than a value selected from the group consisting of: 20. 30, 40, 60, 80, 100nm.
5. The OLED according to claim 1, wherein at least one of the compounds S1 and S2 has the formula M (L 1)x(L2)y(L3)z;
Wherein L 1、L2 and L 3 may be the same or different;
wherein x is 1, 2 or 3;
wherein y is 0,1 or 2;
wherein z is 0,1 or 2;
where x+y+z is the oxidation state of the metal M,
Wherein L 1 is selected from the group consisting of:
Wherein L 2 and L 3 are independently selected from the group consisting of:
wherein T is selected from the group consisting of B, al, ga, and In;
wherein K 1' is a direct bond or is selected from the group consisting of: NR e、PRe, O, S and Se;
Wherein each Y 1 to Y 13 is independently selected from the group consisting of carbon and nitrogen;
wherein Y' is selected from the group consisting of :BRe、NRe、PRe、O、S、Se、C=O、S=O、SO2、CReRf、SiReRf and der eRf;
R e and R f can be fused or joined to form a ring;
Wherein each R a、Rb、Rc and R d is independently capable of representing a single substitution up to the maximum number of substitutions or no substitution possible;
Wherein each R a1、Rb1、Rc1、Rd1、Ra、Rb、Rc、Rd、Re and R f is independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, borane, aralkyl, alkoxy, aryloxy, amino, silyl, germanyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, seleno, and combinations thereof; and
Wherein any two of R a1、Rb1、Rc1、Rd1、Ra、Rb、Rc and R d are capable of fusing or bonding to form a ring or to form a multidentate ligand.
6. The OLED of claim 1, wherein at least one of the compounds S1 and S2 is selected from the group consisting of:
Wherein:
Each of X 96 to X 99 is independently C or N;
Each Y 100 is independently selected from the group consisting of NR ", O, S and Se;
L is independently selected from the group consisting of: direct bond, BR "R '", NR ", PR", O, S, se, C = O, C = S, C =se, c=nr ", c=cr" R ' ", s= O, SO 2, CR" R ' ", siR" R ' ", ger" R ' ", alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof;
X 100 at each occurrence is selected from the group consisting of: o, S, se, NR "and CR" R' ";
each of R 10a、R20a、R30a、R40a and R 50a、RA"、RB"、RC"、RD"、RE" and R F" independently represents mono-to maximum substitution or no substitution;
R、R'、R"、R"'、R10a、R11a、R12a、R13a、R20a、R30a、R40a、R50a、R60、R70、R97、R98、R99、RA1'、RA2'、RA"、RB"、RC"、RD"、RE"、RF"、RG"、RH"、RI"、RJ"、RK"、RL"、RM" And each of R N" is independently hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, germyl, borane, seleno, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
7. The OLED of claim 1, wherein the emissive region further comprises a first host; and/or wherein the emission area further comprises a second body; and/or wherein at least one of the S1 and S2 compounds forms an exciplex with the first host in the OLED at room temperature; and/or wherein one of the first body and the second body is a hole transporting body, the other of the first body and the second body being an electron transporting body; and/or
Wherein the LUMO energy of the first host is lower than the LUMO energy of the compounds S1, S2, A1 and A2 in the emission region; and/or wherein the HOMO energy of the first body is higher than the HOMO energy of at least one of the compounds S1, S2, A1 and A2 in the emission region.
8. The OLED of claim 7, wherein the S1 energy of the first host is greater than the S1 energy of the A1 and A2 compounds; and/or wherein the T1 energy of the first host is greater than the T1 energy of the S1 and S2 compounds; and/or the HOMO energy of the compound S1 is greater than the HOMO energy of the compound A1; and/or the HOMO energy of the compound S2 is greater than the HOMO energy of the compound A2.
9. The OLED of claim 7, wherein the first host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole, 5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, triazine, borane, silane groups, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ 2 -benzo [ d ] benzo [4,5] imidazo [3,2-a ] imidazole and aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene).
10. The OLED of claim 7, wherein the first host is selected from the group consisting of:
Wherein:
Each of X 1 to X 24 is independently C or N;
L' is a direct bond or an organic linking group;
each Y A is independently selected from the group consisting of: absence, bond, O, S, se, CRR ', sir', geRR ', NR, BR, BRR';
Each of R A'、RB'、RC'、RD'、RE'、RF' and R G' independently represents mono-to maximum substitution or no substitution;
R, R', R A'、RB'、RC'、RD'、RE'、RF' and R G' are each independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borane, and combinations thereof;
Adjacent two of R A'、RB'、RC'、RD'、RE'、RF' and R G' are optionally joined or fused to form a ring.
11. The OLED of claim 1, wherein the HOMO level of compound A1 is deeper than at least one selected from the group consisting of compound S1 and the first host; and/or wherein the HOMO level of the compound A2 is deeper than at least one selected from the compound S2 and the first host; and/or wherein each of the compounds S1, S2, A1 and A2 independently has a VDR value equal to or less than 0.33.
12. The OLED of claim 1, wherein the OLED emits luminescent radiation at room temperature when a voltage is applied across the device; wherein the luminescent radiation comprises a first radiation component provided by the compound A1 having an emission lambda max1 and a second radiation component provided by the compound A2 having an emission lambda max2; wherein each of the λ max1 and λ max2 is independently selected from the group consisting of: greater than 340nm to equal to or less than 500nm, greater than 500nm to equal to or less than 600nm, and greater than 600nm to equal to or less than 900nm; and/or wherein the FWHM of the first radiation component is 50nm or less; and/or wherein the FWHM of the second radiation component is 50nm or less; and/or wherein the 10% origin of the emission peak of at least one of the first radiation component and the second radiation component is less than 465nm; and/or wherein the compound S1 is partially or fully deuterated; and/or wherein the compound S2 is partially or fully deuterated; and/or wherein the compound A1 is partially or fully deuterated; and/or wherein the compound A2 is partially or fully deuterated; and/or wherein the first body is partially or fully deuterated; and/or wherein the second body is partially or fully deuterated.
13. An organic light emitting device OLED comprising:
An anode;
A first emission region disposed on the anode;
a first charge generation layer CGL disposed on the first emission region;
a second transmission region disposed on the first CGL; and
A cathode disposed on the second emission region;
Wherein the first emission area includes:
compound S1; and
A compound A1;
Wherein the second emission region includes:
Compound S2; and
Compound A2;
wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2;
Wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter;
wherein the compound S1 may be the same as or different from the compound S2; and
Wherein the compound A1 may be the same as or different from the compound A2.
14. A pixel arrangement of a device, comprising:
a first subpixel comprising a first OLED comprising a first emission region;
A second subpixel comprising a second OLED comprising a second emissive region;
Wherein the first emission area includes:
compound S1; and
A compound A1;
Wherein the second emission region includes:
Compound S2; and
Compound A2;
wherein the compound S1 is a sensitizer that transfers energy to the compound A1; and the compound S2 is a sensitizer that transfers energy to the compound A2;
Wherein each of the compounds A1 and A2 is independently an acceptor that is an emitter;
wherein the compound S1 may be the same as or different from the compound S2; and
Wherein the compound A1 may be the same as or different from the compound A2.
15. A consumer product comprising the OLED of claim 1.
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63/419,782 | 2022-10-27 | ||
US63/421,804 | 2022-11-02 | ||
US63/387,166 | 2022-12-13 | ||
US63/434,161 | 2022-12-21 | ||
US63/483,647 | 2023-02-07 | ||
US63/484,757 | 2023-02-14 | ||
US63/484,786 | 2023-02-14 | ||
US63/487,055 | 2023-02-27 | ||
US63/490,065 | 2023-03-14 | ||
US63/459,091 | 2023-04-13 | ||
US18/319,182 | 2023-05-17 | ||
US18/491,112 | 2023-10-20 | ||
US18/491,112 US20240188319A1 (en) | 2022-10-27 | 2023-10-20 | Organic electroluminescent materials and devices |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117956820A true CN117956820A (en) | 2024-04-30 |
Family
ID=90798895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311406125.XA Pending CN117956820A (en) | 2022-10-27 | 2023-10-27 | Organic electroluminescent material and device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117956820A (en) |
-
2023
- 2023-10-27 CN CN202311406125.XA patent/CN117956820A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022132158A (en) | Organic electroluminescent materials and devices | |
CN115073528A (en) | Organic electroluminescent material and device | |
CN115707267A (en) | Organic electroluminescent material and device | |
CN116903667A (en) | Organic electroluminescent material and device | |
CN116265473A (en) | Organic electroluminescent material and device | |
CN114478483A (en) | Organic electroluminescent material and device | |
CN113292579A (en) | Organic electroluminescent material and device | |
CN117956820A (en) | Organic electroluminescent material and device | |
EP4362631A2 (en) | Organic electroluminescent materials and devices | |
EP4369898A1 (en) | Organic electroluminescent materials and devices | |
CN117956819A (en) | Organic electroluminescent material and device | |
EP4376583A2 (en) | Organic electroluminescent materials and devices | |
US20240180025A1 (en) | Organic electroluminescent materials and devices | |
EP4362645A2 (en) | Organic electroluminescent materials and devices | |
CN117956824A (en) | Organic electroluminescent material and device | |
CN118742075A (en) | Organic electroluminescent material and device | |
CN117956823A (en) | Organic electroluminescent material and device | |
CN117956821A (en) | Organic electroluminescent material and device | |
CN118488726A (en) | Organic electroluminescent material and device | |
CN117956822A (en) | Organic electroluminescent material and device | |
CN118591248A (en) | Organic electroluminescent material and device | |
CN116744711A (en) | Organic electroluminescent material and device | |
CN116744707A (en) | Organic electroluminescent material and device | |
CN117229327A (en) | Organic electroluminescent material and device | |
KR20240059593A (en) | Organic electroluminescent materials and devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |